10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended October 31, 2020

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from                     to                     

Commission File Number 1-14959

BRADY CORPORATION

(Exact name of registrant as specified in its charter)

Wisconsin	39-0178960
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

6555 West Good Hope Road,
Milwaukee,	Wisconsin	53223
(Address of principal executive offices and zip code)

(414) 358-6600

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
Class A Nonvoting Common Stock, par value $0.01 per share	BRC	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes  ☑   No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☑  No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☑	Accelerated filer	☐	Emerging growth company	☐
Non-accelerated filer	☐	Smaller reporting company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐ No  ☑ 

As of November 17, 2020, there were 48,475,600 outstanding shares of Class A Nonvoting Common Stock and 3,538,628 shares of Class B Voting Common Stock. The Class B Voting Common Stock, all of which is held by affiliates of the Registrant, is the only voting stock.

FORM 10-Q

BRADY CORPORATION

INDEX

	Page
PART I. Financial Information	3
Item 1. Financial Statements (Unaudited)	3
Condensed Consolidated Balance Sheets	3
Condensed Consolidated Statements of Income	4
Condensed Consolidated Statements of Comprehensive Income	5
Condensed Consolidated Statements of Cash Flows	6
Notes to Condensed Consolidated Financial Statements	7
Item 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition	17
Item 3. Quantitative and Qualitative Disclosures About Market Risk	23
Item 4. Controls and Procedures	23
PART II. Other Information	24
Item 1A. Risk Factors	24
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	25
Item 6. Exhibits	25
Signatures	26

2

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in Thousands)

	October 31, 2020		July 31, 2020
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	256,333	$	217,643
Accounts receivable, net of allowance for credit losses of $7,704 and $7,157, respectively	156,735		146,181
Inventories	120,220		135,662
Prepaid expenses and other current assets	11,489		9,962
Total current assets	544,777		509,448
Property, plant and equipment—net	119,960		115,068
Goodwill	412,718		416,034
Other intangible assets	20,910		22,334
Deferred income taxes	8,976		8,845
Operating lease assets	41,013		41,899
Other assets	27,353		28,838
Total	$	1,175,707	$	1,142,466
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	62,907	$	62,547
Accrued compensation and benefits	55,410		41,546
Taxes, other than income taxes	8,497		8,057
Accrued income taxes	10,707		8,652
Current operating lease liabilities	16,097		15,304
Other current liabilities	51,343		49,782
Total current liabilities	204,961		185,888
Long-term operating lease liabilities	29,951		31,982
Other liabilities	60,394		61,524
Total liabilities	295,306		279,394
Stockholders’ equity:
Class A nonvoting common stock—Issued 51,261,487 shares, and outstanding 48,497,649 and 48,456,954 shares, respectively	513		513
Class B voting common stock—Issued and outstanding, 3,538,628 shares	35		35
Additional paid-in capital	332,121		331,761
Retained earnings	726,546		704,456
Treasury stock—2,763,838 and 2,804,533 shares, respectively, of Class A nonvoting common stock, at cost	(109,146)		(107,216)
Accumulated other comprehensive loss	(69,668)		(66,477)
Total stockholders’ equity	880,401		863,072
Total	$	1,175,707	$	1,142,466

See Notes to Condensed Consolidated Financial Statements.

3

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Dollars in Thousands, Except Per Share Amounts, Unaudited)

	Three months ended October 31,
	2020		2019
Net sales	$	277,227	$	286,947
Cost of goods sold	141,799		145,542
Gross margin	135,428		141,405
Operating expenses:
Research and development	10,203		10,967
Selling, general and administrative	83,037		89,547
Total operating expenses	93,240		100,514
Operating income	42,188		40,891
Other income (expense):
Investment and other income	155		1,380
Interest expense	(106)		(701)
Income before income taxes and losses of unconsolidated affiliate	42,237		41,570
Income tax expense	8,582		4,072
Income before losses of unconsolidated affiliate	33,655		37,498
Equity in losses of unconsolidated affiliate	(174)		—
Net income	$	33,481	$	37,498
Net income per Class A Nonvoting Common Share:
Basic	$	0.64	$	0.71
Diluted	$	0.64	$	0.70
Dividends	$	0.22	$	0.22
Net income per Class B Voting Common Share:
Basic	$	0.63	$	0.69
Diluted	$	0.62	$	0.68
Dividends	$	0.20	$	0.20
Weighted average common shares outstanding:
Basic	52,021		53,143
Diluted	52,292		53,736

See Notes to Condensed Consolidated Financial Statements.

4

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Dollars in Thousands, Unaudited)

	Three months ended October 31,
	2020		2019
Net income	$	33,481	$	37,498
Other comprehensive loss:
Foreign currency translation adjustments	(4,192)		50
Cash flow hedges:
Net gain recognized in other comprehensive loss	697		196
Reclassification adjustment for losses (gains) included in net income	211		(381)
	908		(185)
Pension and other post-retirement benefits actuarial gain amortization	(106)		(105)
Other comprehensive loss, before tax	(3,390)		(240)
Income tax benefit related to items of other comprehensive loss	199		211
Other comprehensive loss, net of tax	(3,191)		(29)
Comprehensive income	$	30,290	$	37,469

See Notes to Condensed Consolidated Financial Statements.

5

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in Thousands, Unaudited)

	Three months ended October 31,
	2020		2019
Operating activities:
Net income	$	33,481	$	37,498
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	5,635		5,634
Stock-based compensation expense	3,574		3,618
Deferred income taxes	(1,175)		1,009
Equity in losses of unconsolidated affiliate	174		—
Other	(266)		1,533
Changes in operating assets and liabilities:
Accounts receivable	(11,371)		(4,362)
Inventories	14,758		249
Prepaid expenses and other assets	(1,398)		(1,404)
Accounts payable and accrued liabilities	17,363		(5,193)
Income taxes	2,063		266
Net cash provided by operating activities	62,838		38,848
Investing activities:
Purchases of property, plant and equipment	(9,321)		(7,724)
Other	119		527
Net cash used in investing activities	(9,202)		(7,197)
Financing activities:
Payment of dividends	(11,391)		(11,533)
Proceeds from exercise of stock options	160		3,411
Payments for employee taxes withheld from stock-based awards	(2,617)		(7,269)
Purchase of treasury stock	(2,720)		—
Other	17		65
Net cash used in financing activities	(16,551)		(15,326)
Effect of exchange rate changes on cash and cash equivalents	1,605		(304)
Net increase in cash and cash equivalents	38,690		16,021
Cash and cash equivalents, beginning of period	217,643		279,072
Cash and cash equivalents, end of period	$	256,333	$	295,093

See Notes to Condensed Consolidated Financial Statements.

6

BRADY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Three Months Ended October 31, 2020

(Unaudited)

(In thousands, except share and per share amounts)

NOTE A — Basis of Presentation

The condensed consolidated financial statements included herein have been prepared by Brady Corporation and subsidiaries (the "Company," "Brady," "we," or "our") without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of the Company, the foregoing statements contain all adjustments, consisting only of normal recurring adjustments necessary to present fairly the financial position of the Company as of October 31, 2020 and July 31, 2020, its results of operations and comprehensive income for the three months ended October 31, 2020 and 2019, and cash flows for the three months ended October 31, 2020 and 2019. The condensed consolidated balance sheet as of July 31, 2020, has been derived from the audited consolidated financial statements as of that date. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts therein. Due to the inherent uncertainty involved in making estimates, actual results in future periods may differ from the estimates.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to rules and regulations of the Securities and Exchange Commission. Accordingly, the condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statement presentation. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended July 31, 2020.

NOTE B — New Accounting Pronouncements

Adopted Standards

In June 2016, the FASB issued ASU 2016-13, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments," which changes the impairment model for most financial instruments. Prior guidance required the recognition of credit losses based on an incurred loss impairment methodology that reflected losses once the losses were probable. Under ASU 2016-13, the Company is required to use a current expected credit loss model ("CECL") that immediately recognizes an estimate of credit losses that are expected to occur over the life of the financial instruments that are in the scope of this update, including trade receivables. The CECL model uses a broader range of reasonable and supportable information in the development of credit loss estimates. The guidance is effective for interim periods in fiscal years beginning after December 15, 2019. The Company adopted ASU 2016-13 effective August 1, 2020, which did not have a material impact on its consolidated financial statements.

In January 2017, the FASB issued ASU 2017-04, "Goodwill and Other, Simplifying the Test for Goodwill Impairment." The new guidance removes Step 2 of the goodwill impairment test, which required a hypothetical purchase price allocation. A goodwill impairment is now the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. All other goodwill impairment guidance remains largely unchanged. The guidance is effective for interim periods in fiscal years beginning after December 15, 2019. The Company adopted ASC 2017-04 effective August 1, 2020. This guidance only impacts the Company's consolidated financial statements if there is a future impairment of goodwill.

Standards not yet adopted

In December 2019, the FASB issued ASU 2019-12, "Income Taxes - Simplifying the Accounting for Income Taxes (Topic 740)." The new guidance removes certain exceptions to the general principles in ASC 740 such as recognizing deferred taxes for equity investments, the incremental approach to performing intraperiod tax allocation and calculating income taxes in interim periods. The standard also simplifies accounting for income taxes under U.S. GAAP by clarifying and amending existing guidance, including the recognition of deferred taxes for goodwill, the allocation of taxes to members of a consolidated group and requiring that an entity reflect the effect of enacted changes in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. This guidance is effective for annual periods beginning after December 15, 2020, and interim periods thereafter. Early adoption is permitted. The Company is currently evaluating the impact that the adoption of this ASU will have on the consolidated financial statements and related disclosures.

7

In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." Subject to meeting certain criteria, the new guidance provides optional expedients and exceptions to applying contract modification accounting under existing U.S. GAAP, to address the expected phase out of the London Inter-bank Offered Rate ("LIBOR") by the end of 2021. This guidance is effective upon issuance and allows application to contract changes as early as January 1, 2020. Some of the Company's contracts with respect to its borrowing agreements already contain comparable alternative reference rates that would automatically take effect upon the phasing out of LIBOR. The Company is in the process of reviewing its bank facilities and commercial contracts that utilize LIBOR as the reference rate and is currently evaluating the potential impact that the adoption of this ASU will have on the consolidated financial statements and related disclosures.

NOTE C — Additional Balance Sheet Information

Inventories

Inventories as of October 31, 2020, and July 31, 2020, consisted of the following:

	October 31, 2020		July 31, 2020
Finished products	$	74,933	$	85,547
Work-in-process	20,815		24,044
Raw materials and supplies	24,472		26,071
Total inventories	$	120,220	$	135,662

Property, plant and equipment

Property, plant and equipment is presented net of accumulated depreciation in the amount of $269,510 and $276,248 as of October 31, 2020, and July 31, 2020, respectively.

NOTE D — Other Intangible Assets

Other intangible assets as of October 31, 2020, and July 31, 2020, consisted of the following: 

	October 31, 2020							July 31, 2020
	Weighted Average Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value		Weighted Average Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value
Definite-lived other intangible assets:
Customer relationships and tradenames	9	$	45,346	$	(33,986)	$	11,360	9	$	45,385	$	(32,670)	$	12,715
Indefinite-lived other intangible assets:
Tradenames	N/A	9,550		—		9,550		N/A	9,619		—		9,619
Total		$	54,896	$	(33,986)	$	20,910		$	55,004	$	(32,670)	$	22,334

The change in the gross carrying amount of other intangible assets as of October 31, 2020 compared to July 31, 2020 was due to the effect of currency fluctuations during the three-month period.

Amortization expense on intangible assets was $1,351 and $1,291 for the three months ended October 31, 2020 and 2019, respectively. Amortization expense over each of the next five fiscal years is projected to be $5,404, $5,116, and $2,191 for the fiscal years ending July 31, 2021, 2022, and 2023, respectively. No amortization expense for intangible assets is projected after July 31, 2023.

NOTE E — Leases

The Company leases certain manufacturing facilities, warehouses and office space, computer equipment, and vehicles accounted for as operating leases. Lease terms typically range from one year to ten years. As of October 31, 2020, the Company did not have any finance leases.

8

Operating lease expense was $4,073 and $5,405 for the three months ended October 31, 2020 and 2019, respectively, which was recognized in either "Cost of goods sold" or "Selling, general and administrative expenses" in the condensed consolidated statements of income, based on the nature of the lease. Short-term lease expense, variable lease expenses, and sublease income was immaterial to the condensed consolidated statements of income for the three months ended October 31, 2020 and 2019.

Supplemental cash flow information related to the Company's operating leases for the three months ended October 31, 2020 and 2019, was as follows:

	Three months ended October 31,
	2020		2019
Operating cash flows from operating leases	$	4,297	$	4,010
Operating lease assets obtained in exchange for new operating lease liabilities	2,936		9,952

NOTE F – Stockholders' Equity

The following table illustrates the changes in the balances of each component of stockholders' equity for the three months ended October 31, 2020:

	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total Stockholders' Equity
Balances at July 31, 2020	$	548	$	331,761	$	704,456	$	(107,216)	$	(66,477)	$	863,072
Net income	—		—		33,481		—		—		33,481
Other comprehensive loss, net of tax	—		—		—		—		(3,191)		(3,191)
Issuance of shares of Class A Common Stock under stock plan	—		(3,246)		—		790		—		(2,456)
Tax benefit and withholdings from deferred compensation distributions	—		32		—		—		—		32
Stock-based compensation expense	—		3,574		—		—		—		3,574
Repurchase of shares of Class A Common Stock	—		—		—		(2,720)		—		(2,720)
Cash dividends on Common Stock:
Class A — $0.22 per share	—		—		(10,671)		—		—		(10,671)
Class B — $0.20 per share	—		—		(720)		—		—		(720)
Balances at October 31, 2020	$	548	$	332,121	$	726,546	$	(109,146)	$	(69,668)	$	880,401

The following table illustrates the changes in the balances of each component of stockholders' equity for the three months ended October 31, 2019:

	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total Stockholders' Equity
Balances at July 31, 2019	$	548	$	329,969	$	637,843	$	(46,332)	$	(71,254)	$	850,774
Net income	—		—		37,498		—		—		37,498
Other comprehensive loss, net of tax	—		—		—		—		(29)		(29)
Issuance of shares of Class A Common Stock under stock plan	—		(6,410)		—		2,553		—		(3,857)
Tax benefit and withholdings from deferred compensation distributions	—		64		—		—		—		64
Stock-based compensation expense	—		3,618		—		—		—		3,618
Repurchase of shares of Class A Common Stock	—		—		—		—		—		—
Cash dividends on Common Stock:
Class A — $0.22 per share	—		—		(10,822)		—		—		(10,822)
Class B — $0.20 per share	—		—		(711)		—		—		(711)
Balances at October 31, 2019	$	548	$	327,241	$	663,808	$	(43,779)	$	(71,283)	$	876,535

9

Incentive Stock Plans

The Company has an incentive stock plan under which the Board of Directors may grant nonqualified stock options to purchase shares of Class A Nonvoting Common Stock, restricted stock units ("RSUs"), or restricted and unrestricted shares of Class A Nonvoting Common Stock to employees and non-employee directors. Certain awards may be subject to pre-established performance goals. The majority of the Company’s annual share-based awards are granted in the first quarter of the fiscal year.

Total stock-based compensation expense recognized during the three months ended October 31, 2020 and 2019, was $3,574 ($3,300 net of taxes) and $3,618 ($3,089 net of taxes), respectively. As of October 31, 2020, total unrecognized compensation cost related to share-based awards was $14,460 pre-tax, net of estimated forfeitures, which the Company expects to recognize over a weighted-average period of 2.2 years.

Stock Options

The stock options issued under the plan have an exercise price equal to the fair market value of the underlying stock at the date of grant and generally vest ratably over a three-year period, with one-third becoming exercisable one year after the grant date and one-third additional in each of the succeeding two years. Options issued under the plan, referred to herein as “time-based” options, generally expire 10 years from the date of grant.

The Company has estimated the fair value of its time-based option awards granted during the three months ended October 31, 2020 and 2019, using the Black-Scholes option valuation model. The weighted-average assumptions used in the Black-Scholes valuation model are reflected in the following table:

	Three months ended October 31,
Black-Scholes Option Valuation Assumptions	2020			2019
Expected term (in years)	6.21			6.20
Expected volatility	30.71		%	25.85		%
Expected dividend yield	2.49		%	2.63		%
Risk-free interest rate	0.38		%	1.64		%
Weighted-average market value of underlying stock at grant date	$	39.92		$	54.05
Weighted-average exercise price	$	39.92		$	54.05
Weighted-average fair value of options granted during the period	$	8.65		$	10.63

The following is a summary of stock option activity for the three months ended October 31, 2020:

Time-Based Options	Options Outstanding	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at July 31, 2020	1,273,382	$	37.84
New grants	303,052	39.92
Exercised	(22,300)	29.10
Forfeited or expired	—	—
Outstanding at October 31, 2020	1,554,134	$	38.37	7.2	$	5,410
Exercisable at October 31, 2020	1,004,641	$	34.88	6.1	$	5,410

The total fair value of stock options vested during the three months ended October 31, 2020 and 2019, was $2,371 and $2,537, respectively. The total intrinsic value of stock options exercised during the three months ended October 31, 2020 and 2019, based upon the average market price at the time of exercise during the period, was $373 and $10,225, respectively.

The cash received from the exercise of stock options during the three months ended October 31, 2020 and 2019, was $160 and $3,411, respectively. The tax benefit from the exercise of stock options during the three months ended October 31, 2020 and 2019, was $93 and $2,541, respectively.

RSUs

RSUs issued under the plan have a grant date fair value equal to the fair market value of the underlying stock at the date of grant. Shares issued under the plan are referred to herein as either "time-based" or "performance-based" RSUs. The time-based RSUs issued under the plan generally vest ratably over a three-year period, with one-third vesting one year after the grant date

10

and one-third additional in each of the succeeding two years. The performance-based RSUs granted under the plan vest at the end of a three-year service period provided specified financial performance metrics are met.

The following tables summarize the RSU activity for the three months ended October 31, 2020:

Time-Based RSUs	Shares	Weighted Average Grant Date Fair Value
Outstanding at July 31, 2020	154,960	$	47.39
New grants	75,352	39.92
Vested	(63,339)	44.85
Forfeited	—	—
Outstanding at October 31, 2020	166,973	$	44.98

The time-based RSUs granted during the three months ended October 31, 2019, had a weighted-average grant date fair value of $54.10.

Performance-Based RSUs	Shares	Weighted Average Grant Date Fair Value
Outstanding at July 31, 2020	126,060	$	50.61
New grants (1)	64,634	60.73
Vested (1)	(71,413)	33.12
Forfeited	—	—
Outstanding at October 31, 2020	119,281	$	61.05

(1) Includes 23,805 shares granted and vested during the three months ended October 31, 2020, resulting from the payout of performance-based RSUs granted in fiscal year 2018 due to achievement of performance metrics exceeding the target payout.

The performance-based RSUs granted during the three months ended October 31, 2020, had a weighted-average grant-date fair value determined by a third-party valuation involving the use of a Monte Carlo simulation. The performance-based RSUs granted during the three months ended October 31, 2019, had a weighted-average grant date fair value of $75.00.

The aggregate intrinsic value of time-based and performance-based RSUs vested during the three months ended October 31, 2020 and 2019, was $5,844 and $8,708, respectively.

NOTE G — Accumulated Other Comprehensive Loss

Other comprehensive loss consists of foreign currency translation adjustments which includes the settlements of net investment hedges, unrealized gains and losses from cash flow hedges and the unamortized gain on post-retirement plans, net of their related tax effects.

The following table illustrates the changes in the balances of each component of accumulated other comprehensive loss, net of tax, for the three months ended October 31, 2020:

	Unrealized (loss) gain on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
Beginning balance, July 31, 2020	$	(200)	$	2,181	$	(68,458)	$	(66,477)
Other comprehensive income (loss) before reclassification	701		—		(4,185)		(3,484)
Amounts reclassified from accumulated other comprehensive loss	159		134		—		293
Ending balance, October 31, 2020	$	660	$	2,315	$	(72,643)	$	(69,668)

The increase in accumulated other comprehensive loss as of October 31, 2020, compared to July 31, 2020, was primarily due to the appreciation of the U.S. dollar against certain other currencies during the three-month period.

11

The changes in accumulated other comprehensive loss by component, net of tax, for the three months ended October 31, 2019, were as follows:

	Unrealized gain on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
Beginning balance, July 31, 2019	$	707	$	2,800	$	(74,761)	$	(71,254)
Other comprehensive income before reclassification	136		—		226		362
Amounts reclassified from accumulated other comprehensive loss	(286)		(105)		—		(391)
Ending balance, October 31, 2019	$	557	$	2,695	$	(74,535)	$	(71,283)

The increase in the accumulated other comprehensive loss as of October 31, 2019, compared to July 31, 2019, was negligible primarily due to the stability of the U.S. dollar against certain other currencies during the three-month period.

Of the amounts reclassified from accumulated other comprehensive loss during the three months ended October 31, 2020 and 2019, unrealized (losses) gains on cash flow hedges were reclassified to "Cost of goods sold" and unamortized gains on post-retirement plans was reclassified into "Investment and other income" on the condensed consolidated statements of income.

The following table illustrates the income tax benefit on the components of other comprehensive loss for the three months ended October 31, 2020 and 2019:

	Three months ended October 31,
	2020		2019
Income tax benefit related to items of other comprehensive loss:
Cash flow hedges	$	(48)	$	35
Pension and other post-retirement benefits	240		—
Other income tax adjustments and currency translation	7		176
Income tax benefit related to items of other comprehensive loss	$	199	$	211

NOTE H — Revenue Recognition

The Company recognizes revenue when control of the product or service transfers to the customer at an amount that represents the consideration expected to be received in exchange for those products and services. The Company’s revenues are primarily from the sale of identification solutions and workplace safety products that are shipped and billed to customers. All revenue is from contracts with customers and is included in “Net sales” on the condensed consolidated statements of income. See Note I, “Segment Information,” for the Company’s disaggregated revenue disclosure.

The Company offers extended warranty coverage that is included in the sales price of certain products, which it accounts for as service warranties. The Company accounts for the deferred revenue associated with extended service warranties as a contract liability. The balance of contract liabilities associated with service warranty performance obligations was $2,552 and $2,559 as of October 31, 2020 and July 31, 2020, respectively. The current portion and non-current portion of contract liabilities are included in “Other current liabilities” and “Other liabilities," respectively, on the condensed consolidated balance sheets. The Company recognized revenue of $297 and $315 during the three months ended October 31, 2020 and 2019, respectively, that was included in the contract liability balance at the beginning of the respective period from the amortization of extended service warranties. Of the contract liability balance outstanding at October 31, 2020, the Company expects to recognize 32% by the end of fiscal 2021, an additional 31% by the end of fiscal 2022, and the remaining balance thereafter. 

NOTE I — Segment Information

The Company is organized and managed on a global basis within three operating segments, Identification Solutions ("IDS"), Workplace Safety ("WPS"), and People Identification ("PDC"), which aggregate into two reportable segments that are organized around businesses with consistent products and services: IDS and WPS. The IDS and PDC operating segments aggregate into the IDS reporting segment, while the WPS reporting segment is comprised solely of the Workplace Safety operating segment.

12

The following is a summary of net sales by segment and geographic region for the three months ended October 31, 2020 and 2019:

	Three months ended October 31,
	2020		2019
Net sales:
ID Solutions
Americas	$	133,267	$	149,363
Europe	42,582		43,381
Asia	22,343		22,243
Total	$	198,192	$	214,987
Workplace Safety
Americas	$	24,031	$	24,303
Europe	41,266		36,026
Australia	13,738		11,631
Total	$	79,035	$	71,960
Total Company
Americas	$	157,298	$	173,666
Europe	83,848		79,407
Asia-Pacific	36,081		33,874
Total	$	277,227	$	286,947

The following is a summary of segment profit for the three months ended October 31, 2020 and 2019:

	Three months ended October 31,
	2020		2019
Segment profit:
ID Solutions	$	40,279	$	42,443
Workplace Safety	7,988		5,157
Total Company	$	48,267	$	47,600

The following is a reconciliation of segment profit to income before income taxes and losses of unconsolidated affiliate for the three months ended October 31, 2020 and 2019:

	Three months ended October 31,
	2020		2019
Total profit from reportable segments	$	48,267	$	47,600
Unallocated amounts:
Administrative costs	(6,079)		(6,709)
Investment and other income	155		1,380
Interest expense	(106)		(701)
Income before income taxes and losses of unconsolidated affiliate	$	42,237	$	41,570

13

NOTE J — Net Income per Common Share

Reconciliations of the numerator and denominator of the basic and diluted per share computations for the Company’s Class A and Class B common stock are summarized as follows:

	Three months ended October 31,
	2020		2019
Numerator (in thousands):
Net income (Numerator for basic and diluted income per Class A Nonvoting Common Share)	$	33,481	$	37,498
Less:
Preferential dividends	(808)		(828)
Preferential dividends on dilutive stock options	(4)		(10)
Numerator for basic and diluted income per Class B Voting Common Share	$	32,669	$	36,660
Denominator: (in thousands)
Denominator for basic income per share for both Class A and Class B	52,021		53,143
Plus: Effect of dilutive equity awards	271		593
Denominator for diluted income per share for both Class A and Class B	52,292		53,736
Net income per Class A Nonvoting Common Share:
Basic	$	0.64	$	0.71
Diluted	$	0.64	$	0.70
Net income per Class B Voting Common Share:
Basic	$	0.63	$	0.69
Diluted	$	0.62	$	0.68

Potentially dilutive securities attributable to outstanding stock options and restricted stock units were excluded from the calculation of diluted earnings per share where the combined exercise price and average unamortized fair value were greater than the average market price of Brady's Class A Nonvoting Common Stock because the effect would have been anti-dilutive. The amount of anti-dilutive shares were 740,745 and 323,719 for the three months ended October 31, 2020 and 2019, respectively.

NOTE K — Fair Value Measurements

In accordance with fair value accounting guidance, the Company determines fair value based on the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The inputs used to measure fair value are classified into the following hierarchy:

Level 1 — Unadjusted quoted prices in active markets for identical instruments that are accessible as of the reporting date.

Level 2 — Other significant pricing inputs that are either directly or indirectly observable.

Level 3 — Significant unobservable pricing inputs, which result in the use of management's own assumptions.

The following table summarizes the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis at October 31, 2020 and July 31, 2020:

	October 31, 2020		July 31, 2020		Fair Value Hierarchy
Assets:
Trading securities	$	17,434	$	18,606	Level 1
Foreign exchange contracts	1,017		594		Level 2
Liabilities:
Foreign exchange contracts	449		777		Level 2

The following methods and assumptions were used to estimate the fair value of each class of financial instrument:

Trading securities: The Company’s deferred compensation investments consist of investments in mutual funds, which are included in "Other assets" on the condensed consolidated balance sheets. These investments were classified as Level 1 as the shares of these investments trade with sufficient frequency and volume to enable us to obtain pricing information on an ongoing basis.

14

Foreign exchange contracts: The Company’s foreign exchange contracts were classified as Level 2 as the fair value was based on the present value of the future cash flows using external models that use observable inputs, such as interest rates, yield curves and foreign exchange rates. See Note L, “Derivatives and Hedging Activities,” for additional information.

The fair values of cash and cash equivalents, accounts receivable, accounts payable, and other liabilities approximated carrying values due to their short-term nature.

NOTE L — Derivatives and Hedging Activities

The Company utilizes forward foreign exchange currency contracts to reduce the exchange rate risk of specific foreign currency denominated transactions. These contracts typically require the exchange of a foreign currency for U.S. dollars at a fixed rate on a future date, with maturities of less than 18 months, which qualify as cash flow hedges or net investment hedges under the accounting guidance for derivative instruments and hedging activities. The primary objective of the Company’s foreign currency exchange risk management program is to minimize the impact of currency movements due to transactions in other than the respective subsidiaries’ functional currency and to minimize the impact of currency movements on the Company’s net investment denominated in a currency other than the U.S. dollar. To achieve this objective, the Company hedges a portion of known exposures using forward foreign exchange currency contracts.

Main foreign currency exposures are related to transactions denominated in the British Pound, Euro, Canadian dollar, Australian dollar, Mexican Peso, Chinese Yuan, Malaysian Ringgit and Singapore dollar. Generally, these risk management transactions will involve the use of foreign currency derivatives to minimize the impact of currency movements on non-functional currency transactions.

The U.S. dollar equivalent notional amounts of outstanding forward exchange contracts were as follows:

	October 31, 2020		July 31, 2020
Designated as cash flow hedges	$	19,247	$	24,600
Non-designated hedges	3,242		3,107
Total foreign exchange contracts	$	22,489	$	27,707

Cash Flow Hedges

The Company has designated a portion of its forward foreign exchange contracts as cash flow hedges and recorded these contracts at fair value on the condensed consolidated balance sheets. For these instruments, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income ("OCI") and reclassified into income in the same period or periods during which the hedged transaction affects income. As of October 31, 2020 and July 31, 2020, unrealized gains of $523 and losses of $385 have been included in OCI, respectively.

The following table summarizes the amount of pre-tax gains and losses related to foreign exchange contracts designated as cash flow hedging instruments:

	Three months ended October 31,
	2020		2019
Gains recognized in OCI	$	697	$	196
(Losses) gains reclassified from OCI into cost of goods sold	(211)		381

Fair values of derivative instruments in the condensed consolidated balance sheets were as follows: 

	October 31, 2020				July 31, 2020
	Prepaid expenses and other current assets		Other current liabilities		Prepaid expenses and other current assets		Other current liabilities
Derivatives designated as hedging instruments:
Foreign exchange contracts (cash flow hedges)	$	1,017	$	(434)	$	588	$	761
Derivatives not designated as hedging instruments:
Foreign exchange contracts (non-designated hedges)	—		(15)		6		16
Total derivative instruments	$	1,017	$	(449)	$	594	$	777

15

NOTE M – Income Taxes

The effective income tax rate for the three months ended October 31, 2020 and 2019 was 20.3% and 9.8%, respectively. The Company expects its ongoing annual effective income tax rate to be approximately 20% based on its current global business mix. The effective income tax rate for the three months ended October 31, 2019 was lower than the expected income tax rate due to the favorable settlement of a domestic income tax audit and tax benefits from stock-based compensation.

NOTE N — Subsequent Events

On November 17, 2020, the Board of Directors declared a quarterly cash dividend to shareholders of the Company’s Class A and Class B Common Stock of $0.22 per share payable on January 29, 2021, to shareholders of record at the close of business on January 8, 2020.

16

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION

Overview

Brady Corporation is a global manufacturer and supplier of identification solutions and workplace safety products that identify and protect premises, products and people. The IDS segment is primarily involved in the design, manufacture, and distribution of high-performance and innovative safety, identification and healthcare products. The WPS segment provides workplace safety, identification and compliance products, approximately half of which are internally manufactured and half of which are externally sourced.

The ability to provide customers with a broad range of proprietary, customized and diverse products for use in various applications across multiple industries and geographies, along with a commitment to quality and service, have made Brady a leader in many of its markets. The long-term sales growth and profitability of our segments will depend not only on improved demand in end markets and the overall economic environment, but also on our ability to continuously improve the efficiency of our global operations, deliver a high level of customer service, develop and market innovative new products, and to advance our digital capabilities. In our IDS business, our strategy for growth includes an increased focus on certain industries and products, a focus on improving the customer buying experience, and the development of technologically advanced, innovative and proprietary products. In our WPS business, our strategy for growth includes a focus on workplace safety critical industries, innovative new product offerings, compliance expertise, customization expertise, and improving our digital capabilities.

The following are key initiatives supporting our strategy in fiscal 2021:

•Investing in organic growth by enhancing our research and development process and utilizing customer feedback to develop innovative new products.

•Providing our customers with the highest level of customer service.

•Expanding and enhancing our sales capabilities through an improved digital presence and the use of data-driven marketing automation tools.

•Driving operational excellence and executing sustainable efficiency gains within our global operations and within our selling, general and administrative structures.

•Building on our culture of diversity and inclusion to increase employee engagement and enhance recruitment and retention practices.

Impact of the COVID-19 Pandemic on Our Business

The impact of the COVID-19 pandemic on the global economic environment has resulted in reduced demand across the majority of our end markets. In the near-term, the COVID-19 pandemic is expected to continue to have adverse effects on our sales, overall profitability, and cash provided by operating activities. As of the date of this filing, significant uncertainty exists concerning the magnitude of the impact and duration of the COVID-19 pandemic.

Brady Corporation is deemed an essential business under the majority of local government orders. Our products support first responders, healthcare workers, food processing companies, and many other critical industries. During the quarter ended October 31, 2020, our facilities were operating globally with enhanced safety protocols designed to protect the health and safety of our employees.

We have taken actions throughout our business to reduce controllable costs, including actions to reduce labor costs, eliminating non-essential travel, and reducing discretionary spend. We believe we have the financial strength to continue to invest in organic sales growth opportunities and research and development ("R&D"), while continuing to drive sustainable efficiencies and automation in our operations and selling, general and administrative expenses ("SG&A") functions. At October 31, 2020, we had cash of $256.3 million, an undrawn credit facility of $200 million, which can be increased up to $400 million at the Company's option and subject to certain conditions, and outstanding letters of credit of $3.5 million, for total available liquidity of approximately $653 million.

Due to the speed with which the COVID-19 pandemic developed and the resulting uncertainty, including the depth and duration of any disruptions to customers and suppliers, its future effect on our business, results of operations, and financial condition cannot be predicted. Despite this uncertainty, we believe that our financial resources, liquidity levels and debt-free status, along with various contingency plans to reduce costs are sufficient to manage the impact of the COVID-19 pandemic, which may result in reduced sales, reduced net income, and reduced cash provided by operating activities. Refer to Risk Factors, included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended July 31, 2020, for further discussion of the possible impact of the COVID-19 pandemic on our business.

17

Results of Operations

A comparison of results of operating income for the three months ended October 31, 2020 and 2019 is as follows:

	Three months ended October 31,
(Dollars in thousands)	2020		% Sales		2019		% Sales
Net sales	$	277,227			$	286,947
Gross margin	135,428		48.9	%	141,405		49.3	%
Operating expenses:
Research and development	10,203		3.7	%	10,967		3.8	%
Selling, general and administrative	83,037		30.0	%	89,547		31.2	%
Total operating expenses	93,240		33.6	%	100,514		35.0	%
Operating income	$	42,188	15.2	%	$	40,891	14.3	%

References in this Form 10-Q to “organic sales” refer to sales calculated in accordance with GAAP, excluding the impact of foreign currency translation. The Company's organic sales disclosures exclude the effects of foreign currency translation as foreign currency translation is subject to volatility that can obscure underlying business trends. Management believes that the non-GAAP financial measure of organic sales is meaningful to investors as it provides them with useful information to aid in identifying underlying sales trends in our businesses and facilitating comparisons of our sales performance with prior periods.

Net sales for the three months ended October 31, 2020, decreased 3.4% to $277.2 million, compared to $286.9 million in the same period in the prior year. The decrease consisted of an organic sales decline of 4.9% and an increase from foreign currency translation of 1.5%. Organic sales declined 8.4% in the IDS segment and grew 5.5% in the WPS segment during the three months ended October 31, 2020, compared to the same period in the prior year.

The COVID-19 pandemic had a significant impact on organic sales during the three months ended October 31, 2020, with the impact varying between the IDS and WPS segments. The IDS segment realized reduced demand across all major product lines, while the WPS segment realized increased demand globally for personal protective equipment and other pandemic-related safety and identification products during this same period.

Gross margin for the three months ended October 31, 2020, decreased 4.2% to $135.4 million, compared to $141.4 million in the same period in the prior year. As a percentage of net sales, gross margin decreased to 48.9% for the three months ended October 31, 2020, from 49.3% in the same period in the prior year. The decrease in gross margin as a percentage of net sales was primarily due to the decline in sales volumes in the IDS segment resulting from the economic slowdown caused by the COVID-19 pandemic as well as product mix in our WPS segment, which was partially mitigated by our ongoing efforts to streamline manufacturing processes and drive sustainable operational efficiencies.

R&D expenses for the three months ended October 31, 2020, declined 7.0% to $10.2 million, compared to $11.0 million in the same period in the prior year. As a percentage of sales, R&D expenses declined slightly to 3.7% for the three months ended October 31, 2020, compared to 3.8% in the same period in the prior year. The decrease in R&D spending was due to a decrease in headcount, improved efficiency, and the timing of expenditures related to ongoing new product development costs compared to the same period in the prior year. The Company remains committed to investing in new product development to increase sales within our IDS and WPS businesses. Investments in new printers and materials continue to be the primary focus of R&D expenditures.

SG&A expenses include selling and administrative costs directly attributed to the IDS and WPS segments, as well as certain other corporate administrative expenses including finance, information technology, human resources, and other administrative expenses. SG&A expenses declined 7.3% to $83.0 million for the three months ended October 31, 2020, compared to $89.5 million in the same period in the prior year. As a percentage of sales, SG&A was 30.0% for the three months ended October 31, 2020, compared to 31.2% in the same period in the prior year. The decrease in both SG&A expenses and SG&A expenses as a percentage of net sales from the same period of the prior year was primarily due to ongoing efficiency gains, a reduction in the SG&A cost structure, along with a reduction in discretionary spend, including travel for our sales people, which was partially offset by the impact of foreign currency translation.

Operating income increased 3.2% to $42.2 million for three months ended October 31, 2020, compared to $40.9 million in the same period in the prior year. The increase in operating income was primarily due to increased segment profit in the WPS segment as a result of organic sales growth as well as a reduction in the SG&A cost structure in both segments.

18

OPERATING INCOME TO NET INCOME

	Three months ended October 31,
(Dollars in thousands)	2020		% Sales		2019		% Sales
Operating income	$	42,188	15.2	%	$	40,891	14.3	%
Other income (expense):
Investment and other income	155		0.1	%	1,380		0.5	%
Interest expense	(106)		—	%	(701)		(0.2)	%
Income before income tax and losses of unconsolidated affiliate	42,237		15.2	%	41,570		14.5	%
Income tax expense	8,582		3.1	%	4,072		1.4	%
Income before losses of unconsolidated affiliate	33,655		12.1	%	37,498		13.1	%
Equity in losses of unconsolidated affiliate	(174)		(0.1)	%	—		—	%
Net income	$	33,481	12.1	%	$	37,498	13.1	%

Investment and other income was $0.2 million for the three months ended October 31, 2020, compared to $1.4 million for the same period in the prior year. The decrease was primarily due to reduced interest income as a result of the decline in interest rates.

Interest expense decreased to $0.1 million for the three months ended October 31, 2020, compared to $0.7 million for the same period in the prior year. The decrease in interest expense was due to the repayment of the Company's remaining principal balance under its private placement debt agreement during the fourth quarter of the fiscal year ended July 31, 2020.

The Company’s income tax rate was 20.3% for the three months ended October 31, 2020, compared to 9.8% in the same period in the prior year. Refer to Note M "Income Taxes" for additional information on the Company's effective income tax rate.

Equity in losses of unconsolidated affiliate of $0.2 million for the three months ended October 31, 2020 represented the Company's proportionate share of the loss in its equity interest in React Mobile, Inc., an employee safety software and hardware company based in the United States.

Business Segment Operating Results

The Company evaluates short-term segment performance based on segment profit and customer sales. Interest expense, investment and other income, income tax expense, equity in losses of unconsolidated affiliate, and certain corporate administrative expenses are excluded when evaluating segment performance.

The following is a summary of segment information for the three months ended October 31, 2020 and 2019:

	Three months ended October 31,
	2020		2019
SALES GROWTH INFORMATION
ID Solutions
Organic	(8.4)	%	(0.2)	%
Currency	0.6	%	(1.2)	%
Total	(7.8)	%	(1.4)	%
Workplace Safety
Organic	5.5	%	(0.8)	%
Currency	4.3	%	(3.4)	%
Total	9.8	%	(4.2)	%
Total Company
Organic	(4.9)	%	(0.4)	%
Currency	1.5	%	(1.7)	%
Total	(3.4)	%	(2.1)	%
SEGMENT PROFIT AS A PERCENT OF NET SALES
ID Solutions	20.3	%	19.7	%
Workplace Safety	10.1	%	7.2	%
Total	17.4	%	16.6	%

19

ID Solutions

IDS net sales decreased 7.8% for the three months ended October 31, 2020, compared to the same period in the prior year, which consisted of an organic sales decline of 8.4% and an increase from foreign currency translation of 0.6%. The economic slowdown caused by the COVID-19 pandemic had a significant impact on organic sales during the quarter, which resulted in organic sales declines across all major product lines for the three months ended October 31, 2020.

Organic sales in the Americas declined in the high-single digits for the three months ended October 31, 2020, compared to the same period in the prior year. Organic sales declined across all major product lines due to the economic slowdown caused by the COVID-19 pandemic. Organic sales declined by approximately 10% in the United States and declined in the low-single digits in remainder of the Americas region.

Organic sales in Europe declined in the mid-single digits for the three months ended October 31, 2020, as compared to the same period in the prior year. Organic sales declined across all major product lines due to the economic slowdown caused by the COVID-19 pandemic. The organic sales decline was broad-based throughout Western Europe, which was partially offset by mid-single digit organic sales growth for certain businesses based in emerging geographies.

Organic sales in Asia declined in the low-single digits for the three months ended October 31, 2020, as compared to the same period in the prior year. Organic sales growth in the safety and facility identification and wire identification product lines was offset by an organic sales decline in the product identification product line. The low-single digit decline was broad-based throughout Asia.

Segment profit decreased 5.1% to $40.3 million for the three months ended October 31, 2020, compared to $42.4 million in the same period in the prior year. As a percentage of net sales, segment profit was 20.3% for the three months ended October 31, 2020, compared to 19.7% in the same period in the prior year. The increase in segment profit as a percentage of sales was primarily driven by the reduced cost structure throughout the IDS segment and a reduction in discretionary spending in response to the decline in revenue from the impact of the COVID-19 pandemic.

Workplace Safety

WPS net sales increased 9.8% for the three months ended October 31, 2020, compared to the same period in the prior year, which consisted of organic sales growth of 5.5% and an increase from foreign currency translation of 4.3%. Sales through the digital channel increased in the mid-teens and sales through the traditional catalog channel increased in the low-single digits. The WPS business realized increased demand globally for personal protective equipment, social distancing signage and floor markings, and other COVID-19 pandemic-related products.

Organic sales in Europe increased in the high-single digits for the three months ended October 31, 2020, compared to the same period in the prior year. Sales through the digital channel increased in the mid-teens, which was driven by digital marketing campaigns emphasizing personal protective equipment and other COVID-19 pandemic-related products. Sales through the traditional catalog channel increased in the mid-single digits. Organic sales growth in Europe was led by businesses in France followed by growth in Norway and the U.K., which was partially offset by a decline in organic sales in Germany.

Organic sales in North America declined in the low-single digits for the three months ended October 31, 2020, compared to the same period in the prior year. This decrease was driven by a low-single digit decline in traditional catalog sales, which was partially offset by low-single digit growth in sales through the digital channel. The increase in digital sales was primarily due to increased sales of personal protective equipment, social distancing signage and floor markings, and other COVID-19 pandemic-related products.

Organic sales in Australia increased just over 10% for the three months ended October 31, 2020, compared to the same period of the prior year. Digital channel sales grew approximately 40% over the same period in the prior year, which was driven by digital marketing campaigns emphasizing personal protective equipment along with floor markings and signage related to social distancing and personal hygiene. Sales through the traditional catalog channel increased in the mid-single digits. Our Australian business generated increased sales in a variety of product categories related to mitigating the COVID-19 pandemic, including various types of personal protective equipment and other healthcare supplies.

Segment profit increased to $8.0 million for the three months ended October 31, 2020, compared to $5.2 million in the same period of the prior year. As a percentage of net sales, segment profit increased to 10.1% for the three months ended October 31, 2020, compared to 7.2% in the same period of the prior year. The increase in segment profit was primarily driven by increased organic sales volumes combined with the reduced SG&A cost structure, and to a lesser extent foreign currency translation.

20

Liquidity and Capital Resources

The Company's cash balances are generated and held in numerous locations throughout the world. At October 31, 2020, approximately 66% of the Company's cash and cash equivalents were held outside the United States. The Company's growth has historically been funded by a combination of cash provided by operating activities and debt financing. The Company believes that its cash flow from operating activities and its borrowing capacity are sufficient to fund its anticipated requirements for working capital, capital expenditures, research and development, common stock repurchases, and dividend payments for the next 12 months. Although the Company believes these sources of cash are currently sufficient to fund domestic operations, annual cash needs could require repatriation of cash to the U.S. from foreign jurisdictions, which may result in additional tax payments.

Cash Flows

Cash and cash equivalents were $256.3 million at October 31, 2020, an increase of $38.7 million from July 31, 2020. The significant changes were as follows:

	Three months ended October 31,
(Dollars in thousands)	2020		2019
Net cash flow provided by (used in):
Operating activities	$	62,838	$	38,848
Investing activities	(9,202)		(7,197)
Financing activities	(16,551)		(15,326)
Effect of exchange rate changes on cash	1,605		(304)
Net increase in cash and cash equivalents	$	38,690	$	16,021

Net cash provided by operating activities was $62.8 million for the three months ended October 31, 2020, compared to $38.8 million in the same period of the prior year. The increase was primarily due to an increase in cash provided by working capital. Inventory levels were reduced which resulted in the majority of the increase in cash provided by operating activities, which was due to a planned reduction in inventory following a period of increased balances to reduce the risk of supply chain disruption resulting from the COVID-19 pandemic. In addition, the timing of accounts payable and other compensation-related withholding increased cash provided by working capital, which was partially offset by a decrease in cash provided by accounts receivable due to increasing sequential sales during the quarter.

Net cash used in investing activities was $9.2 million for the three months ended October 31, 2020, compared to $7.2 million used in the same period of the prior year. The increase in cash used in investing activities was primarily driven by an increase in capital expenditures for the purchase of facility upgrades and manufacturing equipment in Europe, the United States, and Mexico.

Net cash used in financing activities was $16.6 million during the three months ended October 31, 2020, compared to $15.3 million used in the same period of the prior year. The increase in cash used in financing activities was primarily driven by $2.7 million of share repurchases and a decrease in cash proceeds from the exercise of stock options, which was largely offset by a decrease in cash payments for employee taxes withheld from stock-based awards.

Credit Facilities

On August 1, 2019, the Company and certain of its subsidiaries entered into an unsecured $200 million multi-currency revolving loan agreement with a group of five banks that replaced and terminated the Company’s previous loan agreement that had been entered into on September 25, 2015. Under the new revolving loan agreement, the Company has the option to select either a Eurocurrency rate loan that bears interest at the LIBOR rate plus a margin based on the Company's consolidated net leverage ratio or a base interest rate (based upon the higher of the federal funds rate plus 0.5%, the prime rate of the Bank of Montreal plus a margin based on the Company’s consolidated net leverage ratio, or the Eurocurrency base rate at the LIBOR rate plus a margin based on the Company’s consolidated net leverage ratio plus 1%). At the Company's option, and subject to certain conditions, the available amount under the revolving loan agreement may be increased from $200 million to $400 million. The maximum amount outstanding on the Company's revolving loan agreement during the three months ended October 31, 2020 was $10.6 million. As of October 31, 2020, there were no borrowings outstanding on the credit facility. The Company had letters of credit outstanding under the loan agreement of $3.5 million as of October 31, 2020 and there was $196.5 million available for future borrowing, which can be increased to $396.5 million at the Company's option, subject to

21

certain conditions. The revolving loan agreement has a final maturity date of August 1, 2024, as such, any borrowing would be classified as long-term on the accompanying condensed consolidated balance sheets.

Covenant Compliance

The Company's revolving loan agreement requires it to maintain certain financial covenants, including a ratio of debt to the trailing twelve months EBITDA, as defined in the debt agreements, of not more than a 3.5 to 1.0 ratio (leverage ratio) and the trailing twelve months EBITDA to interest expense of not less than a 3.0 to 1.0 ratio (interest expense coverage). As of October 31, 2020, the Company was in compliance with these financial covenants.

Off-Balance Sheet Arrangements

The Company does not have material off-balance sheet arrangements. The Company is not aware of factors that are reasonably likely to adversely affect liquidity trends, other than the risk factors described in this and other Company filings. However, the following additional information is provided to assist those reviewing the Company’s financial statements.

Purchase Commitments - The Company has purchase commitments for materials, supplies, services, and property, plant and equipment as part of the ordinary conduct of its business. In the aggregate, such commitments are not in excess of current market prices and are not material to the financial position of the Company. Due to the proprietary nature of many of the Company’s materials and processes, certain supply contracts contain penalty provisions for early termination. The Company does not believe a material amount of penalties will be incurred under these contracts based upon historical experience and current expectations.

Other Contractual Obligations - The Company does not have material financial guarantees or other contractual commitments that are reasonably likely to adversely affect liquidity.

Forward-Looking Statements

In this quarterly report on Form 10-Q, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, income, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.

The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project” or “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady's control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from:

•Adverse impacts of the novel coronavirus ("COVID-19") pandemic or other pandemics

•Decreased demand for the Company's products

•Ability to compete effectively or to successfully execute its strategy

•Ability to develop technologically advanced products that meet customer demands

•Raw material and other cost increases

•Difficulties in protecting websites, networks, and systems against security breaches

•Extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities

•Risks associated with the loss of key employees

•Divestitures, contingent liabilities from divestitures and the failure to identify, integrate, and grow acquired companies

•Litigation, including product liability claims

•Foreign currency fluctuations

•Potential write-offs of goodwill and other intangible assets

•Changes in tax legislation and tax rates

•Differing interests of voting and non-voting shareholders

•Numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady's U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady's Form 10-K for the year ended July 31, 2020.

These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.

22

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Refer to the Company’s annual report on Form 10-K for the year ended July 31, 2020. There has been no material change in this information since July 31, 2020.

ITEM 4. CONTROLS AND PROCEDURES

Brady Corporation maintains a set of disclosure controls and procedures that are designed to ensure that information required to be disclosed by the Company in the reports filed by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports the Company files under the Exchange Act is accumulated and communicated to the Company’s management, including the Company’s principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company carried out an evaluation, under the supervision and with the participation of its management, including its President and Chief Executive Officer and its Chief Financial Officer and Treasurer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rule 13a-15 of the Exchange Act. Based on that evaluation, the Company’s President & Chief Executive Officer and Chief Financial Officer and Treasurer concluded that the Company’s disclosure controls and procedures are effective as of the end of the period covered by this report.

There were no changes in the Company's internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the Company's most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

23

PART II. OTHER INFORMATION

ITEM 1A. RISK FACTORS

The Company’s business, results of operations, financial condition, and cash flows are subject to various risks and uncertainties, including those described in Part I, Item 1A, “Risk Factors” of Brady's Annual Report on Form 10-K for the year ended July 31, 2020. Other than as set forth below, there have been no material changes from the risk factors set forth in the 2020 Form 10-K.

Our results of operations have been and will in the future be adversely impacted by the COVID-19 pandemic or other pandemics, and the duration and extent to which it will impact our business and financial results remains uncertain.

The global spread of COVID-19 has resulted in significant economic disruption, has negatively impacted our financial results, and significantly increased future uncertainty. The extent to which the COVID-19 pandemic will continue to impact our business, results of operations, and financial condition will depend on numerous evolving factors and future developments, which are highly uncertain and cannot be predicted at this time. Such factors and developments may include the geographic spread, severity and duration of the COVID-19 pandemic, including whether there are periods of increased COVID-19 cases, disruption to our operations resulting from employee illnesses, the development and availability of effective treatment or vaccines, the extent and duration of the impact on the U.S. or global economy, including the pace and extent of recovery when the pandemic subsides, and the actions that have been and may be taken by various governmental authorities in response to the outbreak, including mandatory facility closures of non-essential businesses, stay-at-home orders, or similar restrictions, all of which may continue to effect our customers and customers' demand for our services and products, reduce demand for healthcare services, impact our suppliers or cause disruptions in the global supply chain, and impact our ability to sell and manufacture our products. Certain jurisdictions have begun lifting stay-at-home orders only to impose further restrictions in the wake of increases in new COVID-19 cases. As such, there is considerable uncertainty regarding how current and future health and safety measures implemented in response to the COVID-19 pandemic will impact our business. In addition, the deterioration of macroeconomic conditions may impact the proper functioning of financial and capital markets, foreign currency exchange rates, commodity and energy prices, and interest rates. Even after the COVID-19 pandemic subsides, we may continue to experience adverse impacts to our business and financial results due to any economic recession or depression that has occurred, and due to any major public health crises that may occur in the future.

Although our current accounting estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations and financial position. In particular, a number of estimates have been and will continue to be affected by the ongoing COVID-19 pandemic. The severity, magnitude and duration, as well as the economic consequences of the COVID-19 pandemic, are uncertain, rapidly changing and difficult to predict. As a result, our accounting estimates and assumptions may change over time in response to COVID-19. Such changes could result in future impairments of goodwill, intangible assets, long-lived assets, incremental credit losses on accounts receivable, excess and obsolete inventory, or a decrease in the carrying amount of our deferred tax assets. Any of these events could amplify the other risks and uncertainties described in our Annual Report on Form 10-K for the fiscal year ended July 31, 2020 and could have an adverse effect on our business and financial results.

24

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The Company has a share repurchase program for the Company's Class A Nonvoting Common Stock. The plan may be implemented by purchasing shares in the open market or in privately negotiated transactions, with repurchased shares available for use in connection with the Company's stock-based plans and for other corporate purposes. On February 16, 2016, the Company's Board of Directors authorized a share repurchase program of 2,000,000 shares. As of October 31, 2020, 369,142 shares remained authorized to purchase in connection with this share repurchase program.

The following table provides information with respect to the purchase of Class A Nonvoting Common Stock during the three months ended October 31, 2020:

Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans	Maximum Number of Shares That May Yet Be Purchased Under the Plans
August 1, 2020 - August 31, 2020	—	$	—	—	461,796
September 1, 2020 - September 30, 2020	62,364	39.11		62,364	399,432
October 1, 2020 - October 31, 2020	30,290	38.10		30,290	369,142
Total	92,654	$	38.78	92,654	369,142

ITEM 6. EXHIBITS

Exhibit No.	Exhibit Description
31.1	Rule 13a-14(a)/15d-14(a) Certification of J. Michael Nauman
31.2	Rule 13a-14(a)/15d-14(a) Certification of Aaron J. Pearce
32.1	Section 1350 Certification of J. Michael Nauman
32.2	Section 1350 Certification of Aaron J. Pearce
101.INS	XBRL Instance Document (The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.)
101.SCH	XBRL Taxonomy Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Presentation Label Linkbase Document
104	Cover Page Inline XBRL data (contained in Exhibit 101)

25

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

SIGNATURES

	BRADY CORPORATION
Date: November 19, 2020	/s/ J. MICHAEL NAUMAN
	J. Michael Nauman
	President and Chief Executive Officer
	(Principal Executive Officer)
Date: November 19, 2020	/s/ AARON J. PEARCE
	Aaron J. Pearce
	Chief Financial Officer and Treasurer
	(Principal Financial Officer)

26

EX-31.1

EXHIBIT 31.1

RULE 13a-14(a)/15d-14(a) CERTIFICATION

I, J. Michael Nauman, certify that:

(1) I have reviewed this quarterly report on Form 10-Q of Brady Corporation;

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material act necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4) I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision to provided reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5) I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 19, 2020

/s/ J. MICHAEL NAUMAN

President & Chief Executive Officer

(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

RULE 13a-14(a)/15d-14(a) CERTIFICATION

I, Aaron J. Pearce, certify that:

(1) I have reviewed this quarterly report on Form 10-Q of Brady Corporation;

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material act necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4) I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision to provided reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5) I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 19, 2020

/s/ AARON J. PEARCE

Chief Financial Officer and Treasurer

(Principal Financial Officer)

EX-32.1

EXHIBIT 32.1

SECTION 1350 CERTIFICATION

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Brady Corporation (the “Company”) certifies to his knowledge that:

(1) The Quarterly Report on Form 10-Q of the Company for the quarterly period ended October 31, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company.

Date: November 19, 2020

/s/ J. MICHAEL NAUMAN

President & Chief Executive Officer

(Principal Executive Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. This certification accompanies this report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

EX-32.2

EXHIBIT 32.2

SECTION 1350 CERTIFICATION

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Brady Corporation (the “Company”) certifies to his knowledge that:

(1) The Quarterly Report on Form 10-Q of the Company for the quarterly period ended October 31, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company.

Date: November 19, 2020

/s/ AARON J. PEARCE

Chief Financial Officer and Treasurer

(Principal Financial Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. This certification accompanies this report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

XML

Document and Entity Information - shares	3 Months Ended
	Oct. 31, 2020	Nov. 17, 2020
Entity Information [Line Items]
Document Type	10-Q
Entity Registrant Name	BRADY CORP
Document Quarterly Report	true
Document Transition Report	false
Security Exchange Name	NYSE
Title of 12(b) Security	Class A Nonvoting Common Stock, par value $0.01 per share
Trading Symbol	BRC
Entity File Number	1-14959
Entity Interactive Data Current	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Tax Identification Number	39-0178960
Entity Address, Address Line One	6555 West Good Hope Road,
Entity Address, State or Province	WI
Entity Address, Postal Zip Code	53223
Entity Incorporation, State or Country Code	WI
City Area Code	Milwaukee,
City Area Code	414
Local Phone Number	358-6600
Document Period End Date	Oct. 31, 2020
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Entity Central Index Key	0000746598
Current Fiscal Year End Date	--07-31
Class A nonvoting common stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		48,475,600
Class B Voting Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		3,538,628

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Oct. 31, 2020	Jul. 31, 2020
Current assets:
Cash and cash equivalents	$ 256,333	$ 217,643
Accounts receivable, net of allowance for credit losses of $7,704 and $7,157, respectively	156,735	146,181
Inventories	120,220	135,662
Prepaid expenses and other current assets	11,489	9,962
Total current assets	544,777	509,448
Assets, Noncurrent [Abstract]
Property, plant and equipment—net	119,960	115,068
Goodwill	412,718	416,034
Other intangible assets	20,910	22,334
Deferred income taxes	8,976	8,845
Operating lease assets	41,013	41,899
Other assets	27,353	28,838
Total	1,175,707	1,142,466
Current liabilities:
Accounts payable	62,907	62,547
Accrued compensation and benefits	55,410	41,546
Taxes, other than income taxes	8,497	8,057
Accrued income taxes	10,707	8,652
Current operating lease liabilities	16,097	15,304
Other current liabilities	51,343	49,782
Total current liabilities	204,961	185,888
Long-term operating lease liabilities	29,951	31,982
Other liabilities	60,394	61,524
Total liabilities	295,306	279,394
Stockholders’ equity:
Class A nonvoting common stock—Issued 51,261,487 shares, and outstanding 48,497,649 and 48,456,954 shares, respectively	513	513
Class B voting common stock—Issued and outstanding, 3,538,628 shares	35	35
Additional paid-in capital	332,121	331,761
Retained earnings	726,546	704,456
Treasury stock—2,763,838 and 2,804,533 shares, respectively, of Class A nonvoting common stock, at cost	(109,146)	(107,216)
Accumulated other comprehensive loss	(69,668)	(66,477)
Total stockholders’ equity	880,401	863,072
Total	$ 1,175,707	$ 1,142,466

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Oct. 31, 2020	Jul. 31, 2020
Accounts Receivable, Allowance for Credit Loss, Current	$ 7,704	$ 7,157
Class A nonvoting common stock
Common stock, shares issued	51,261,487	51,261,487
Common stock, shares outstanding	48,497,649	48,456,954
Treasury stock, shares	2,763,838	2,804,533
Class B Voting Common Stock
Common stock, shares issued	3,538,628	3,538,628
Common stock, shares outstanding	3,538,628	3,538,628

XML

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Net sales	$ 277,227	$ 286,947
Cost of goods sold	141,799	145,542
Gross margin	135,428	141,405
Operating expenses:
Research and development	10,203	10,967
Selling, general and administrative	83,037	89,547
Total operating expenses	93,240	100,514
Operating income	42,188	40,891
Other income (expense):
Investment and other income	155	1,380
Interest expense	(106)	(701)
Income before income taxes and losses of unconsolidated affiliate	42,237	41,570
Income tax expense	8,582	4,072
Income (Loss) From Continuing Operations Before Income (Loss) From Equity Method Investments	33,655	37,498
Income (Loss) from Equity Method Investments	(174)	0
Net income	$ 33,481	$ 37,498
Weighted average common shares outstanding:
Weighted average common shares outstanding, basic (in thousands):	52,021	53,143
Weighted average common shares outstanding, diluted (in thousands):	52,292	53,736
Class A Nonvoting Common Stock
Earnings Per Share
Net income per share, basic	$ 0.64	$ 0.71
Net income per share, diluted	0.64	0.70
Dividends	0.22	0.22
Class B Voting Common Stock
Earnings Per Share
Net income per share, basic	0.63	0.69
Net income per share, diluted	0.62	0.68
Dividends	$ 0.20	$ 0.20

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 33,481	$ 37,498
Foreign currency translation adjustments:
Foreign currency translation adjustments	(4,192)	50
Cash flow hedges:
Reclassification adjustment for losses (gains) included in net income	211	(381)
Total cash flow hedges	908	(185)
Pension and other post-retirement benefits:
Pension and other post-retirement benefits actuarial gain amortization	(106)	(105)
Other comprehensive loss, before tax	(3,390)	(240)
Income tax benefit related to items of other comprehensive loss	199	211
Other comprehensive loss, net of tax	(3,191)	(29)
Comprehensive income	$ 30,290	$ 37,469

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Statement of Cash Flows [Abstract]
Net income	$ 33,481	$ 37,498
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	5,635	5,634
Stock-based compensation expense	3,574	3,618
Deferred income taxes	(1,175)	1,009
Income (Loss) from Equity Method Investments	174	0
Other Noncash Income (Expense)	(266)	1,533
Changes in operating assets and liabilities (net of effects of business acquisitions/divestitures):
Accounts receivable	(11,371)	(4,362)
Inventories	14,758	249
Prepaid expenses and other assets	(1,398)	(1,404)
Accounts payable and accrued liabilities	17,363	(5,193)
Income taxes	2,063	266
Net cash provided by operating activities	62,838	38,848
Investing activities:
Purchases of property, plant and equipment	(9,321)	(7,724)
Other	119	527
Net cash used in investing activities	(9,202)	(7,197)
Financing activities:
Payment of dividends	(11,391)	(11,533)
Proceeds from exercise of stock options	160	3,411
Payments for employee taxes withheld from stock-based awards	(2,617)	(7,269)
Purchase of treasury stock	(2,720)	0
Other	17	65
Net cash used in financing activities	(16,551)	(15,326)
Effect of exchange rate changes on cash and cash equivalents	1,605	(304)
Net increase in cash and cash equivalents	38,690	16,021
Cash and cash equivalents, beginning of period	217,643	279,072
Cash and cash equivalents, end of period	$ 256,333	$ 295,093

XML

Basis of Presentation

3 Months Ended

Oct. 31, 2020

Text Block [Abstract]

Basis of Presentation

Basis of Presentation

The condensed consolidated financial statements included herein have been prepared by Brady Corporation and subsidiaries (the "Company," "Brady," "we," or "our") without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of the Company, the foregoing statements contain all adjustments, consisting only of normal recurring adjustments necessary to present fairly the financial position of the Company as of October 31, 2020 and July 31, 2020, its results of operations and comprehensive income for the three months ended October 31, 2020 and 2019, and cash flows for the three months ended October 31, 2020 and 2019. The condensed consolidated balance sheet as of July 31, 2020, has been derived from the audited consolidated financial statements as of that date. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts therein. Due to the inherent uncertainty involved in making estimates, actual results in future periods may differ from the estimates.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to rules and regulations of the Securities and Exchange Commission. Accordingly, the condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statement presentation. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended July 31, 2020.

XML

Additional Balance Sheet Disclosures (Notes)

3 Months Ended

Oct. 31, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Supplemental Balance Sheet Disclosures

Additional Balance Sheet Information

Inventories

Inventories as of October 31, 2020, and July 31, 2020, consisted of the following:

	October 31, 2020		July 31, 2020
Finished products	$	74,933	$	85,547
Work-in-process	20,815		24,044
Raw materials and supplies	24,472		26,071
Total inventories	$	120,220	$	135,662

Property, plant and equipment

Property, plant and equipment is presented net of accumulated depreciation in the amount of $269,510 and $276,248 as of October 31, 2020, and July 31, 2020, respectively.

XML

Goodwill and Intangible Assets

3 Months Ended

Oct. 31, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets Disclosure [Text Block]

Other Intangible Assets

Other intangible assets as of October 31, 2020, and July 31, 2020, consisted of the following: 

	October 31, 2020							July 31, 2020
	Weighted Average Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value		Weighted Average Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value
Definite-lived other intangible assets:
Customer relationships and tradenames	9	$	45,346	$	(33,986)	$	11,360	9	$	45,385	$	(32,670)	$	12,715
Indefinite-lived other intangible assets:
Tradenames	N/A	9,550		—		9,550		N/A	9,619		—		9,619
Total		$	54,896	$	(33,986)	$	20,910		$	55,004	$	(32,670)	$	22,334

The change in the gross carrying amount of other intangible assets as of October 31, 2020 compared to July 31, 2020 was due to the effect of currency fluctuations during the three-month period.

Amortization expense on intangible assets was $1,351 and $1,291 for the three months ended October 31, 2020 and 2019, respectively. Amortization expense over each of the next five fiscal years is projected to be $5,404, $5,116, and $2,191 for the fiscal years ending July 31, 2021, 2022, and 2023, respectively. No amortization expense for intangible assets is projected after July 31, 2023.

XML

Leases (Notes)

3 Months Ended

Oct. 31, 2020

Leases [Abstract]

Lessee, Operating Leases

LeasesThe Company leases certain manufacturing facilities, warehouses and office space, computer equipment, and vehicles accounted for as operating leases. Lease terms typically range from one year to ten years. As of October 31, 2020, the Company did not have any finance leases.

Operating lease expense was $4,073 and $5,405 for the three months ended October 31, 2020 and 2019, respectively, which was recognized in either "Cost of goods sold" or "Selling, general and administrative expenses" in the condensed consolidated statements of income, based on the nature of the lease. Short-term lease expense, variable lease expenses, and sublease income was immaterial to the condensed consolidated statements of income for the three months ended October 31, 2020 and 2019.

Supplemental cash flow information related to the Company's operating leases for the three months ended October 31, 2020 and 2019, was as follows:

	Three months ended October 31,
	2020		2019
Operating cash flows from operating leases	$	4,297	$	4,010
Operating lease assets obtained in exchange for new operating lease liabilities	2,936		9,952

XML

Revenue Recognition Revenue Recognition (Notes)	3 Months Ended
	Oct. 31, 2020
Revenue Recognition [Abstract]
Revenue Recognition, Policy [Policy Text Block]	Revenue RecognitionThe Company recognizes revenue when control of the product or service transfers to the customer at an amount that represents the consideration expected to be received in exchange for those products and services. The Company’s revenues are primarily from the sale of identification solutions and workplace safety products that are shipped and billed to customers. All revenue is from contracts with customers and is included in “Net sales” on the condensed consolidated statements of income. See Note I, “Segment Information,” for the Company’s disaggregated revenue disclosure. The Company offers extended warranty coverage that is included in the sales price of certain products, which it accounts for as service warranties. The Company accounts for the deferred revenue associated with extended service warranties as a contract liability. The balance of contract liabilities associated with service warranty performance obligations was $2,552 and $2,559 as of October 31, 2020 and July 31, 2020, respectively. The current portion and non-current portion of contract liabilities are included in “Other current liabilities” and “Other liabilities," respectively, on the condensed consolidated balance sheets. The Company recognized revenue of $297 and $315 during the three months ended October 31, 2020 and 2019, respectively, that was included in the contract liability balance at the beginning of the respective period from the amortization of extended service warranties. Of the contract liability balance outstanding at October 31, 2020, the Company expects to recognize 32% by the end of fiscal 2021, an additional 31% by the end of fiscal 2022, and the remaining balance thereafter.

XML

Stockholders' Equity (Notes)

3 Months Ended

Oct. 31, 2020

Stockholders' Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

Stockholders' Equity

The following table illustrates the changes in the balances of each component of stockholders' equity for the three months ended October 31, 2020:

	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total Stockholders' Equity
Balances at July 31, 2020	$	548	$	331,761	$	704,456	$	(107,216)	$	(66,477)	$	863,072
Net income	—		—		33,481		—		—		33,481
Other comprehensive loss, net of tax	—		—		—		—		(3,191)		(3,191)
Issuance of shares of Class A Common Stock under stock plan	—		(3,246)		—		790		—		(2,456)
Tax benefit and withholdings from deferred compensation distributions	—		32		—		—		—		32
Stock-based compensation expense	—		3,574		—		—		—		3,574
Repurchase of shares of Class A Common Stock	—		—		—		(2,720)		—		(2,720)
Cash dividends on Common Stock:
Class A — $0.22 per share	—		—		(10,671)		—		—		(10,671)
Class B — $0.20 per share	—		—		(720)		—		—		(720)
Balances at October 31, 2020	$	548	$	332,121	$	726,546	$	(109,146)	$	(69,668)	$	880,401

The following table illustrates the changes in the balances of each component of stockholders' equity for the three months ended October 31, 2019:

	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total Stockholders' Equity
Balances at July 31, 2019	$	548	$	329,969	$	637,843	$	(46,332)	$	(71,254)	$	850,774
Net income	—		—		37,498		—		—		37,498
Other comprehensive loss, net of tax	—		—		—		—		(29)		(29)
Issuance of shares of Class A Common Stock under stock plan	—		(6,410)		—		2,553		—		(3,857)
Tax benefit and withholdings from deferred compensation distributions	—		64		—		—		—		64
Stock-based compensation expense	—		3,618		—		—		—		3,618
Repurchase of shares of Class A Common Stock	—		—		—		—		—		—
Cash dividends on Common Stock:
Class A — $0.22 per share	—		—		(10,822)		—		—		(10,822)
Class B — $0.20 per share	—		—		(711)		—		—		(711)
Balances at October 31, 2019	$	548	$	327,241	$	663,808	$	(43,779)	$	(71,283)	$	876,535

Incentive Stock Plans

The Company has an incentive stock plan under which the Board of Directors may grant nonqualified stock options to purchase shares of Class A Nonvoting Common Stock, restricted stock units ("RSUs"), or restricted and unrestricted shares of Class A Nonvoting Common Stock to employees and non-employee directors. Certain awards may be subject to pre-established performance goals. The majority of the Company’s annual share-based awards are granted in the first quarter of the fiscal year.

Total stock-based compensation expense recognized during the three months ended October 31, 2020 and 2019, was $3,574 ($3,300 net of taxes) and $3,618 ($3,089 net of taxes), respectively. As of October 31, 2020, total unrecognized compensation cost related to share-based awards was $14,460 pre-tax, net of estimated forfeitures, which the Company expects to recognize over a weighted-average period of 2.2 years.

Stock Options

The stock options issued under the plan have an exercise price equal to the fair market value of the underlying stock at the date of grant and generally vest ratably over a three-year period, with one-third becoming exercisable one year after the grant date and one-third additional in each of the succeeding two years. Options issued under the plan, referred to herein as “time-based” options, generally expire 10 years from the date of grant.

The Company has estimated the fair value of its time-based option awards granted during the three months ended October 31, 2020 and 2019, using the Black-Scholes option valuation model. The weighted-average assumptions used in the Black-Scholes valuation model are reflected in the following table:

	Three months ended October 31,
Black-Scholes Option Valuation Assumptions	2020			2019
Expected term (in years)	6.21			6.20
Expected volatility	30.71		%	25.85		%
Expected dividend yield	2.49		%	2.63		%
Risk-free interest rate	0.38		%	1.64		%
Weighted-average market value of underlying stock at grant date	$	39.92		$	54.05
Weighted-average exercise price	$	39.92		$	54.05
Weighted-average fair value of options granted during the period	$	8.65		$	10.63

The following is a summary of stock option activity for the three months ended October 31, 2020:

Time-Based Options	Options Outstanding	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at July 31, 2020	1,273,382	$	37.84
New grants	303,052	39.92
Exercised	(22,300)	29.10
Forfeited or expired	—	—
Outstanding at October 31, 2020	1,554,134	$	38.37	7.2	$	5,410
Exercisable at October 31, 2020	1,004,641	$	34.88	6.1	$	5,410

The total fair value of stock options vested during the three months ended October 31, 2020 and 2019, was $2,371 and $2,537, respectively. The total intrinsic value of stock options exercised during the three months ended October 31, 2020 and 2019, based upon the average market price at the time of exercise during the period, was $373 and $10,225, respectively.

The cash received from the exercise of stock options during the three months ended October 31, 2020 and 2019, was $160 and $3,411, respectively. The tax benefit from the exercise of stock options during the three months ended October 31, 2020 and 2019, was $93 and $2,541, respectively.

RSUs

RSUs issued under the plan have a grant date fair value equal to the fair market value of the underlying stock at the date of grant. Shares issued under the plan are referred to herein as either "time-based" or "performance-based" RSUs. The time-based RSUs issued under the plan generally vest ratably over a three-year period, with one-third vesting one year after the grant date

and one-third additional in each of the succeeding two years. The performance-based RSUs granted under the plan vest at the end of a three-year service period provided specified financial performance metrics are met.

The following tables summarize the RSU activity for the three months ended October 31, 2020:

Time-Based RSUs	Shares	Weighted Average Grant Date Fair Value
Outstanding at July 31, 2020	154,960	$	47.39
New grants	75,352	39.92
Vested	(63,339)	44.85
Forfeited	—	—
Outstanding at October 31, 2020	166,973	$	44.98

The time-based RSUs granted during the three months ended October 31, 2019, had a weighted-average grant date fair value of $54.10.

Performance-Based RSUs	Shares	Weighted Average Grant Date Fair Value
Outstanding at July 31, 2020	126,060	$	50.61
New grants (1)	64,634	60.73
Vested (1)	(71,413)	33.12
Forfeited	—	—
Outstanding at October 31, 2020	119,281	$	61.05

(1) Includes 23,805 shares granted and vested during the three months ended October 31, 2020, resulting from the payout of performance-based RSUs granted in fiscal year 2018 due to achievement of performance metrics exceeding the target payout.

The performance-based RSUs granted during the three months ended October 31, 2020, had a weighted-average grant-date fair value determined by a third-party valuation involving the use of a Monte Carlo simulation. The performance-based RSUs granted during the three months ended October 31, 2019, had a weighted-average grant date fair value of $75.00.

The aggregate intrinsic value of time-based and performance-based RSUs vested during the three months ended October 31, 2020 and 2019, was $5,844 and $8,708, respectively.

XML

Other Comprehensive Income Other Comprehensive Income (Loss)

3 Months Ended

Oct. 31, 2020

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Comprehensive Income (Loss) Note

Accumulated Other Comprehensive Loss

Other comprehensive loss consists of foreign currency translation adjustments which includes the settlements of net investment hedges, unrealized gains and losses from cash flow hedges and the unamortized gain on post-retirement plans, net of their related tax effects.

The following table illustrates the changes in the balances of each component of accumulated other comprehensive loss, net of tax, for the three months ended October 31, 2020:

	Unrealized (loss) gain on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
Beginning balance, July 31, 2020	$	(200)	$	2,181	$	(68,458)	$	(66,477)
Other comprehensive income (loss) before reclassification	701		—		(4,185)		(3,484)
Amounts reclassified from accumulated other comprehensive loss	159		134		—		293
Ending balance, October 31, 2020	$	660	$	2,315	$	(72,643)	$	(69,668)

The increase in accumulated other comprehensive loss as of October 31, 2020, compared to July 31, 2020, was primarily due to the appreciation of the U.S. dollar against certain other currencies during the three-month period.

The changes in accumulated other comprehensive loss by component, net of tax, for the three months ended October 31, 2019, were as follows:

	Unrealized gain on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
Beginning balance, July 31, 2019	$	707	$	2,800	$	(74,761)	$	(71,254)
Other comprehensive income before reclassification	136		—		226		362
Amounts reclassified from accumulated other comprehensive loss	(286)		(105)		—		(391)
Ending balance, October 31, 2019	$	557	$	2,695	$	(74,535)	$	(71,283)

The increase in the accumulated other comprehensive loss as of October 31, 2019, compared to July 31, 2019, was negligible primarily due to the stability of the U.S. dollar against certain other currencies during the three-month period.

Of the amounts reclassified from accumulated other comprehensive loss during the three months ended October 31, 2020 and 2019, unrealized (losses) gains on cash flow hedges were reclassified to "Cost of goods sold" and unamortized gains on post-retirement plans was reclassified into "Investment and other income" on the condensed consolidated statements of income.

The following table illustrates the income tax benefit on the components of other comprehensive loss for the three months ended October 31, 2020 and 2019:

	Three months ended October 31,
	2020		2019
Income tax benefit related to items of other comprehensive loss:
Cash flow hedges	$	(48)	$	35
Pension and other post-retirement benefits	240		—
Other income tax adjustments and currency translation	7		176
Income tax benefit related to items of other comprehensive loss	$	199	$	211

XML

Segment Information

3 Months Ended

Oct. 31, 2020

Segment Reporting [Abstract]

Segment Information

Segment InformationThe Company is organized and managed on a global basis within three operating segments, Identification Solutions ("IDS"), Workplace Safety ("WPS"), and People Identification ("PDC"), which aggregate into two reportable segments that are organized around businesses with consistent products and services: IDS and WPS. The IDS and PDC operating segments aggregate into the IDS reporting segment, while the WPS reporting segment is comprised solely of the Workplace Safety operating segment.

The following is a summary of net sales by segment and geographic region for the three months ended October 31, 2020 and 2019:

	Three months ended October 31,
	2020		2019
Net sales:
ID Solutions
Americas	$	133,267	$	149,363
Europe	42,582		43,381
Asia	22,343		22,243
Total	$	198,192	$	214,987
Workplace Safety
Americas	$	24,031	$	24,303
Europe	41,266		36,026
Australia	13,738		11,631
Total	$	79,035	$	71,960
Total Company
Americas	$	157,298	$	173,666
Europe	83,848		79,407
Asia-Pacific	36,081		33,874
Total	$	277,227	$	286,947

The following is a summary of segment profit for the three months ended October 31, 2020 and 2019:

	Three months ended October 31,
	2020		2019
Segment profit:
ID Solutions	$	40,279	$	42,443
Workplace Safety	7,988		5,157
Total Company	$	48,267	$	47,600

The following is a reconciliation of segment profit to income before income taxes and losses of unconsolidated affiliate for the three months ended October 31, 2020 and 2019:

	Three months ended October 31,
	2020		2019
Total profit from reportable segments	$	48,267	$	47,600
Unallocated amounts:
Administrative costs	(6,079)		(6,709)
Investment and other income	155		1,380
Interest expense	(106)		(701)
Income before income taxes and losses of unconsolidated affiliate	$	42,237	$	41,570

XML

Net Income per Common Share

3 Months Ended

Oct. 31, 2020

Earnings Per Share [Abstract]

Net Income per Common Share

Net Income per Common Share

Reconciliations of the numerator and denominator of the basic and diluted per share computations for the Company’s Class A and Class B common stock are summarized as follows:

	Three months ended October 31,
	2020		2019
Numerator (in thousands):
Net income (Numerator for basic and diluted income per Class A Nonvoting Common Share)	$	33,481	$	37,498
Less:
Preferential dividends	(808)		(828)
Preferential dividends on dilutive stock options	(4)		(10)
Numerator for basic and diluted income per Class B Voting Common Share	$	32,669	$	36,660
Denominator: (in thousands)
Denominator for basic income per share for both Class A and Class B	52,021		53,143
Plus: Effect of dilutive equity awards	271		593
Denominator for diluted income per share for both Class A and Class B	52,292		53,736
Net income per Class A Nonvoting Common Share:
Basic	$	0.64	$	0.71
Diluted	$	0.64	$	0.70
Net income per Class B Voting Common Share:
Basic	$	0.63	$	0.69
Diluted	$	0.62	$	0.68

Potentially dilutive securities attributable to outstanding stock options and restricted stock units were excluded from the calculation of diluted earnings per share where the combined exercise price and average unamortized fair value were greater than the average market price of Brady's Class A Nonvoting Common Stock because the effect would have been anti-dilutive. The amount of anti-dilutive shares were 740,745 and 323,719 for the three months ended October 31, 2020 and 2019, respectively.

XML

Fair Value Measurements

3 Months Ended

Oct. 31, 2020

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements

In accordance with fair value accounting guidance, the Company determines fair value based on the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The inputs used to measure fair value are classified into the following hierarchy:

Level 1 — Unadjusted quoted prices in active markets for identical instruments that are accessible as of the reporting date.

Level 2 — Other significant pricing inputs that are either directly or indirectly observable.

Level 3 — Significant unobservable pricing inputs, which result in the use of management's own assumptions.

The following table summarizes the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis at October 31, 2020 and July 31, 2020:

	October 31, 2020		July 31, 2020		Fair Value Hierarchy
Assets:
Trading securities	$	17,434	$	18,606	Level 1
Foreign exchange contracts	1,017		594		Level 2
Liabilities:
Foreign exchange contracts	449		777		Level 2

The following methods and assumptions were used to estimate the fair value of each class of financial instrument:

Trading securities: The Company’s deferred compensation investments consist of investments in mutual funds, which are included in "Other assets" on the condensed consolidated balance sheets. These investments were classified as Level 1 as the shares of these investments trade with sufficient frequency and volume to enable us to obtain pricing information on an ongoing basis.

Foreign exchange contracts: The Company’s foreign exchange contracts were classified as Level 2 as the fair value was based on the present value of the future cash flows using external models that use observable inputs, such as interest rates, yield curves and foreign exchange rates. See Note L, “Derivatives and Hedging Activities,” for additional information.

The fair values of cash and cash equivalents, accounts receivable, accounts payable, and other liabilities approximated carrying values due to their short-term nature.

XML

Derivatives and Hedging Activities

3 Months Ended

Oct. 31, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives and Hedging Activities

Derivatives and Hedging Activities

The Company utilizes forward foreign exchange currency contracts to reduce the exchange rate risk of specific foreign currency denominated transactions. These contracts typically require the exchange of a foreign currency for U.S. dollars at a fixed rate on a future date, with maturities of less than 18 months, which qualify as cash flow hedges or net investment hedges under the accounting guidance for derivative instruments and hedging activities. The primary objective of the Company’s foreign currency exchange risk management program is to minimize the impact of currency movements due to transactions in other than the respective subsidiaries’ functional currency and to minimize the impact of currency movements on the Company’s net investment denominated in a currency other than the U.S. dollar. To achieve this objective, the Company hedges a portion of known exposures using forward foreign exchange currency contracts.

Main foreign currency exposures are related to transactions denominated in the British Pound, Euro, Canadian dollar, Australian dollar, Mexican Peso, Chinese Yuan, Malaysian Ringgit and Singapore dollar. Generally, these risk management transactions will involve the use of foreign currency derivatives to minimize the impact of currency movements on non-functional currency transactions.

The U.S. dollar equivalent notional amounts of outstanding forward exchange contracts were as follows:

	October 31, 2020		July 31, 2020
Designated as cash flow hedges	$	19,247	$	24,600
Non-designated hedges	3,242		3,107
Total foreign exchange contracts	$	22,489	$	27,707

Cash Flow Hedges

The Company has designated a portion of its forward foreign exchange contracts as cash flow hedges and recorded these contracts at fair value on the condensed consolidated balance sheets. For these instruments, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income ("OCI") and reclassified into income in the same period or periods during which the hedged transaction affects income. As of October 31, 2020 and July 31, 2020, unrealized gains of $523 and losses of $385 have been included in OCI, respectively.

The following table summarizes the amount of pre-tax gains and losses related to foreign exchange contracts designated as cash flow hedging instruments:

	Three months ended October 31,
	2020		2019
Gains recognized in OCI	$	697	$	196
(Losses) gains reclassified from OCI into cost of goods sold	(211)		381

Fair values of derivative instruments in the condensed consolidated balance sheets were as follows: 

	October 31, 2020				July 31, 2020
	Prepaid expenses and other current assets		Other current liabilities		Prepaid expenses and other current assets		Other current liabilities
Derivatives designated as hedging instruments:
Foreign exchange contracts (cash flow hedges)	$	1,017	$	(434)	$	588	$	761
Derivatives not designated as hedging instruments:
Foreign exchange contracts (non-designated hedges)	—		(15)		6		16
Total derivative instruments	$	1,017	$	(449)	$	594	$	777

XML

Income Taxes	3 Months Ended
	Oct. 31, 2020
Income Tax Disclosure [Abstract]
Income Tax Disclosure	Income TaxesThe effective income tax rate for the three months ended October 31, 2020 and 2019 was 20.3% and 9.8%, respectively. The Company expects its ongoing annual effective income tax rate to be approximately 20% based on its current global business mix. The effective income tax rate for the three months ended October 31, 2019 was lower than the expected income tax rate due to the favorable settlement of a domestic income tax audit and tax benefits from stock-based compensation.

XML

Subsequent Events	3 Months Ended
	Oct. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsOn November 17, 2020, the Board of Directors declared a quarterly cash dividend to shareholders of the Company’s Class A and Class B Common Stock of $0.22 per share payable on January 29, 2021, to shareholders of record at the close of business on January 8, 2020.

XML

Accounting Changes and Error Corrections (Policies)

3 Months Ended

Oct. 31, 2020

Accounting Changes and Error Corrections [Abstract]

New Accounting Pronouncements, Policy

New Accounting Pronouncements

Adopted Standards

In June 2016, the FASB issued ASU 2016-13, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments," which changes the impairment model for most financial instruments. Prior guidance required the recognition of credit losses based on an incurred loss impairment methodology that reflected losses once the losses were probable. Under ASU 2016-13, the Company is required to use a current expected credit loss model ("CECL") that immediately recognizes an estimate of credit losses that are expected to occur over the life of the financial instruments that are in the scope of this update, including trade receivables. The CECL model uses a broader range of reasonable and supportable information in the development of credit loss estimates. The guidance is effective for interim periods in fiscal years beginning after December 15, 2019. The Company adopted ASU 2016-13 effective August 1, 2020, which did not have a material impact on its consolidated financial statements.

In January 2017, the FASB issued ASU 2017-04, "Goodwill and Other, Simplifying the Test for Goodwill Impairment." The new guidance removes Step 2 of the goodwill impairment test, which required a hypothetical purchase price allocation. A goodwill impairment is now the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. All other goodwill impairment guidance remains largely unchanged. The guidance is effective for interim periods in fiscal years beginning after December 15, 2019. The Company adopted ASC 2017-04 effective August 1, 2020. This guidance only impacts the Company's consolidated financial statements if there is a future impairment of goodwill.

Standards not yet adopted

In December 2019, the FASB issued ASU 2019-12, "Income Taxes - Simplifying the Accounting for Income Taxes (Topic 740)." The new guidance removes certain exceptions to the general principles in ASC 740 such as recognizing deferred taxes for equity investments, the incremental approach to performing intraperiod tax allocation and calculating income taxes in interim periods. The standard also simplifies accounting for income taxes under U.S. GAAP by clarifying and amending existing guidance, including the recognition of deferred taxes for goodwill, the allocation of taxes to members of a consolidated group and requiring that an entity reflect the effect of enacted changes in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. This guidance is effective for annual periods beginning after December 15, 2020, and interim periods thereafter. Early adoption is permitted. The Company is currently evaluating the impact that the adoption of this ASU will have on the consolidated financial statements and related disclosures.

In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." Subject to meeting certain criteria, the new guidance provides optional expedients and exceptions to applying contract modification accounting under existing U.S. GAAP, to address the expected phase out of the London Inter-bank Offered Rate ("LIBOR") by the end of 2021. This guidance is effective upon issuance and allows application to contract changes as early as January 1, 2020. Some of the Company's contracts with respect to its borrowing agreements already contain comparable alternative reference rates that would automatically take effect upon the phasing out of LIBOR. The Company is in the process of reviewing its bank facilities and commercial contracts that utilize LIBOR as the reference rate and is currently evaluating the potential impact that the adoption of this ASU will have on the consolidated financial statements and related disclosures.

XML

Additional Balance Sheet Disclosures (Tables)

3 Months Ended

Oct. 31, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Inventory, Current [Table Text Block]

Inventories as of October 31, 2020, and July 31, 2020, consisted of the following:

	October 31, 2020		July 31, 2020
Finished products	$	74,933	$	85,547
Work-in-process	20,815		24,044
Raw materials and supplies	24,472		26,071
Total inventories	$	120,220	$	135,662

XML

Goodwill and Intangible Assets (Tables)

3 Months Ended

Oct. 31, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Other Intangible Assets

Other intangible assets as of October 31, 2020, and July 31, 2020, consisted of the following: 

	October 31, 2020							July 31, 2020
	Weighted Average Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value		Weighted Average Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value
Definite-lived other intangible assets:
Customer relationships and tradenames	9	$	45,346	$	(33,986)	$	11,360	9	$	45,385	$	(32,670)	$	12,715
Indefinite-lived other intangible assets:
Tradenames	N/A	9,550		—		9,550		N/A	9,619		—		9,619
Total		$	54,896	$	(33,986)	$	20,910		$	55,004	$	(32,670)	$	22,334

XML

Leases (Tables)

3 Months Ended

Oct. 31, 2020

Leases [Abstract]

Schedule of Cash Flow, Supplemental Disclosures [Text Block]

Supplemental cash flow information related to the Company's operating leases for the three months ended October 31, 2020 and 2019, was as follows:

	Three months ended October 31,
	2020		2019
Operating cash flows from operating leases	$	4,297	$	4,010
Operating lease assets obtained in exchange for new operating lease liabilities	2,936		9,952

XML

Revenue Recognition Remaining Performance Obligation (Tables)	3 Months Ended
	Oct. 31, 2020
Revenue from Contract with Customer [Abstract]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]	Of the contract liability balance outstanding at October 31, 2020, the Company expects to recognize 32% by the end of fiscal 2021, an additional 31% by the end of fiscal 2022, and the remaining balance thereafter.

XML

Stockholders' Equity (Tables)

3 Months Ended

Oct. 31, 2020

Oct. 31, 2019

Stockholders' Equity Note [Abstract]

Schedule of Stockholders Equity [Table Text Block]

The following table illustrates the changes in the balances of each component of stockholders' equity for the three months ended October 31, 2020:

	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total Stockholders' Equity
Balances at July 31, 2020	$	548	$	331,761	$	704,456	$	(107,216)	$	(66,477)	$	863,072
Net income	—		—		33,481		—		—		33,481
Other comprehensive loss, net of tax	—		—		—		—		(3,191)		(3,191)
Issuance of shares of Class A Common Stock under stock plan	—		(3,246)		—		790		—		(2,456)
Tax benefit and withholdings from deferred compensation distributions	—		32		—		—		—		32
Stock-based compensation expense	—		3,574		—		—		—		3,574
Repurchase of shares of Class A Common Stock	—		—		—		(2,720)		—		(2,720)
Cash dividends on Common Stock:
Class A — $0.22 per share	—		—		(10,671)		—		—		(10,671)
Class B — $0.20 per share	—		—		(720)		—		—		(720)
Balances at October 31, 2020	$	548	$	332,121	$	726,546	$	(109,146)	$	(69,668)	$	880,401

The following table illustrates the changes in the balances of each component of stockholders' equity for the three months ended October 31, 2019:

	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total Stockholders' Equity
Balances at July 31, 2019	$	548	$	329,969	$	637,843	$	(46,332)	$	(71,254)	$	850,774
Net income	—		—		37,498		—		—		37,498
Other comprehensive loss, net of tax	—		—		—		—		(29)		(29)
Issuance of shares of Class A Common Stock under stock plan	—		(6,410)		—		2,553		—		(3,857)
Tax benefit and withholdings from deferred compensation distributions	—		64		—		—		—		64
Stock-based compensation expense	—		3,618		—		—		—		3,618
Repurchase of shares of Class A Common Stock	—		—		—		—		—		—
Cash dividends on Common Stock:
Class A — $0.22 per share	—		—		(10,822)		—		—		(10,822)
Class B — $0.20 per share	—		—		(711)		—		—		(711)
Balances at October 31, 2019	$	548	$	327,241	$	663,808	$	(43,779)	$	(71,283)	$	876,535

XML

Stock-Based Compensation (Tables)

3 Months Ended

Oct. 31, 2020

Share-based Payment Arrangement, Disclosure [Abstract]

Black-Scholes Option Valuation Assumptions

The weighted-average assumptions used in the Black-Scholes valuation model are reflected in the following table:

	Three months ended October 31,
Black-Scholes Option Valuation Assumptions	2020			2019
Expected term (in years)	6.21			6.20
Expected volatility	30.71		%	25.85		%
Expected dividend yield	2.49		%	2.63		%
Risk-free interest rate	0.38		%	1.64		%
Weighted-average market value of underlying stock at grant date	$	39.92		$	54.05
Weighted-average exercise price	$	39.92		$	54.05
Weighted-average fair value of options granted during the period	$	8.65		$	10.63

Summary of Stock Option Activity

The following is a summary of stock option activity for the three months ended October 31, 2020:

Time-Based Options	Options Outstanding	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at July 31, 2020	1,273,382	$	37.84
New grants	303,052	39.92
Exercised	(22,300)	29.10
Forfeited or expired	—	—
Outstanding at October 31, 2020	1,554,134	$	38.37	7.2	$	5,410
Exercisable at October 31, 2020	1,004,641	$	34.88	6.1	$	5,410

Summary of RSU Activity

The following tables summarize the RSU activity for the three months ended October 31, 2020:

Time-Based RSUs	Shares	Weighted Average Grant Date Fair Value
Outstanding at July 31, 2020	154,960	$	47.39
New grants	75,352	39.92
Vested	(63,339)	44.85
Forfeited	—	—
Outstanding at October 31, 2020	166,973	$	44.98

Schedule of Nonvested Performance-based Units Activity [Table Text Block]

Performance-Based RSUs	Shares	Weighted Average Grant Date Fair Value
Outstanding at July 31, 2020	126,060	$	50.61
New grants (1)	64,634	60.73
Vested (1)	(71,413)	33.12
Forfeited	—	—
Outstanding at October 31, 2020	119,281	$	61.05

(1) Includes 23,805 shares granted and vested during the three months ended October 31, 2020, resulting from the payout of performance-based RSUs granted in fiscal year 2018 due to achievement of performance metrics exceeding the target payout.

XML

Other Comprehensive Income (Tables)

3 Months Ended

Oct. 31, 2020

Oct. 31, 2019

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)

The following table illustrates the changes in the balances of each component of accumulated other comprehensive loss, net of tax, for the three months ended October 31, 2020:

	Unrealized (loss) gain on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
Beginning balance, July 31, 2020	$	(200)	$	2,181	$	(68,458)	$	(66,477)
Other comprehensive income (loss) before reclassification	701		—		(4,185)		(3,484)
Amounts reclassified from accumulated other comprehensive loss	159		134		—		293
Ending balance, October 31, 2020	$	660	$	2,315	$	(72,643)	$	(69,668)

The changes in accumulated other comprehensive loss by component, net of tax, for the three months ended October 31, 2019, were as follows:

	Unrealized gain on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
Beginning balance, July 31, 2019	$	707	$	2,800	$	(74,761)	$	(71,254)
Other comprehensive income before reclassification	136		—		226		362
Amounts reclassified from accumulated other comprehensive loss	(286)		(105)		—		(391)
Ending balance, October 31, 2019	$	557	$	2,695	$	(74,535)	$	(71,283)

Other Comprehensive Income , Tax

The following table illustrates the income tax benefit on the components of other comprehensive loss for the three months ended October 31, 2020 and 2019:

	Three months ended October 31,
	2020		2019
Income tax benefit related to items of other comprehensive loss:
Cash flow hedges	$	(48)	$	35
Pension and other post-retirement benefits	240		—
Other income tax adjustments and currency translation	7		176
Income tax benefit related to items of other comprehensive loss	$	199	$	211

XML

Segment Information (Tables)

3 Months Ended

Oct. 31, 2020

Segment Reporting [Abstract]

Revenue from External Customers by Geographic Areas [Table Text Block]

The following is a summary of net sales by segment and geographic region for the three months ended October 31, 2020 and 2019:

	Three months ended October 31,
	2020		2019
Net sales:
ID Solutions
Americas	$	133,267	$	149,363
Europe	42,582		43,381
Asia	22,343		22,243
Total	$	198,192	$	214,987
Workplace Safety
Americas	$	24,031	$	24,303
Europe	41,266		36,026
Australia	13,738		11,631
Total	$	79,035	$	71,960
Total Company
Americas	$	157,298	$	173,666
Europe	83,848		79,407
Asia-Pacific	36,081		33,874
Total	$	277,227	$	286,947

Schedule of Segment Reporting Information by Segment

The following is a summary of segment profit for the three months ended October 31, 2020 and 2019:

	Three months ended October 31,
	2020		2019
Segment profit:
ID Solutions	$	40,279	$	42,443
Workplace Safety	7,988		5,157
Total Company	$	48,267	$	47,600

Reconciliation of Segment Profit

The following is a reconciliation of segment profit to income before income taxes and losses of unconsolidated affiliate for the three months ended October 31, 2020 and 2019:

	Three months ended October 31,
	2020		2019
Total profit from reportable segments	$	48,267	$	47,600
Unallocated amounts:
Administrative costs	(6,079)		(6,709)
Investment and other income	155		1,380
Interest expense	(106)		(701)
Income before income taxes and losses of unconsolidated affiliate	$	42,237	$	41,570

XML

Net Income per Common Share (Tables)

3 Months Ended

Oct. 31, 2020

Earnings Per Share [Abstract]

Reconciliations of Numerator and Denominator of Basic and Diluted Per Share

Reconciliations of the numerator and denominator of the basic and diluted per share computations for the Company’s Class A and Class B common stock are summarized as follows:

	Three months ended October 31,
	2020		2019
Numerator (in thousands):
Net income (Numerator for basic and diluted income per Class A Nonvoting Common Share)	$	33,481	$	37,498
Less:
Preferential dividends	(808)		(828)
Preferential dividends on dilutive stock options	(4)		(10)
Numerator for basic and diluted income per Class B Voting Common Share	$	32,669	$	36,660
Denominator: (in thousands)
Denominator for basic income per share for both Class A and Class B	52,021		53,143
Plus: Effect of dilutive equity awards	271		593
Denominator for diluted income per share for both Class A and Class B	52,292		53,736
Net income per Class A Nonvoting Common Share:
Basic	$	0.64	$	0.71
Diluted	$	0.64	$	0.70
Net income per Class B Voting Common Share:
Basic	$	0.63	$	0.69
Diluted	$	0.62	$	0.68

XML

Fair Value Measurements (Tables)

3 Months Ended

Oct. 31, 2020

Fair Value Disclosures [Abstract]

Financial Assets and Liabilities Accounted for at Fair Value on a Recurring Basis

The following table summarizes the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis at October 31, 2020 and July 31, 2020:

	October 31, 2020		July 31, 2020		Fair Value Hierarchy
Assets:
Trading securities	$	17,434	$	18,606	Level 1
Foreign exchange contracts	1,017		594		Level 2
Liabilities:
Foreign exchange contracts	449		777		Level 2

XML

Derivatives and Hedging Activities (Tables)

3 Months Ended

Oct. 31, 2020

Jul. 31, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]

The following table summarizes the amount of pre-tax gains and losses related to foreign exchange contracts designated as cash flow hedging instruments:

	Three months ended October 31,
	2020		2019
Gains recognized in OCI	$	697	$	196
(Losses) gains reclassified from OCI into cost of goods sold	(211)		381

Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]

The U.S. dollar equivalent notional amounts of outstanding forward exchange contracts were as follows:

	October 31, 2020		July 31, 2020
Designated as cash flow hedges	$	19,247	$	24,600
Non-designated hedges	3,242		3,107
Total foreign exchange contracts	$	22,489	$	27,707

Fair Values of Derivative Instruments in Consolidated Balance Sheets

Fair values of derivative instruments in the condensed consolidated balance sheets were as follows: 

	October 31, 2020				July 31, 2020
	Prepaid expenses and other current assets		Other current liabilities		Prepaid expenses and other current assets		Other current liabilities
Derivatives designated as hedging instruments:
Foreign exchange contracts (cash flow hedges)	$	1,017	$	(434)	$	588	$	761
Derivatives not designated as hedging instruments:
Foreign exchange contracts (non-designated hedges)	—		(15)		6		16
Total derivative instruments	$	1,017	$	(449)	$	594	$	777

XML

Additional Balance Sheet Disclosures (Details) - USD ($) $ in Thousands	Oct. 31, 2020	Jul. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$ (269,510)	$ (276,248)
Inventory, Finished Goods, Net of Reserves	74,933	85,547
Inventory, Work in Process, Net of Reserves	20,815	24,044
Inventory, Raw Materials, Net of Reserves	24,472	26,071
Inventories	$ 120,220	$ 135,662

XML

Other Intangible Assets (Detail) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Jul. 31, 2019	Jul. 31, 2020
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Amortization of Intangible Assets	$ 1,351	$ 1,291
Intangible Assets, Amortization Expense, Next Twelve Months	5,404
Intangible Assets, Amortization Expense, Year Two	5,116
Intangible Assets, Amortization Expense, Year Three	$ 2,191
Other Intangible Assets [Line Items]
Weighted Average Amortization Period	9 years		9 years
Intangible Assets, Gross (Excluding Goodwill)	$ 54,896			$ 55,004
Finite-Lived Intangible Assets, Gross	45,346			45,385
Accumulated Amortization	(33,986)			(32,670)
Finite-Lived Intangible Assets, Net	11,360			12,715
Net Book Value	20,910			22,334
Indefinite-lived Intangible Assets (Excluding Goodwill)	$ 9,550			$ 9,619

XML

Leases (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Leases [Abstract]
Operating Lease, Payments	$ 4,297	$ 4,010
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	2,936	9,952
Operating Lease, Cost	$ 4,073	$ 5,405

XML

Revenue Recognition Revenue Recognition (Details) - USD ($)	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Jul. 31, 2020
Revenue Recognition [Abstract]
Contract with Customer, Liability	$ 2,552,000		$ 2,559,000
Deferred Revenue, Revenue Recognized	$ 297,000	$ 315,000

XML

Stockholders' Equity (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Jul. 31, 2020	Jul. 31, 2019
Schedule Of Stockholders Equity [Line Items]
Additional paid-in capital	$ 332,121		$ 331,761
Retained earnings	726,546		704,456
Treasury Stock, Value	109,146		107,216
Accumulated other comprehensive loss	(69,668)		(66,477)	$ (71,254)
Stockholders' Equity Attributable to Parent	880,401	$ 876,535	863,072	850,774
Net income	33,481	37,498
Other Comprehensive Income (Loss), Net of Tax	(3,191)	(29)
Stock Issued During Period, Value, Stock Options Exercised	(2,456)	(3,857)
Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation	32	64
Share-based Payment Arrangement, Noncash Expense	3,574	3,618
Treasury Stock, Value, Acquired, Cost Method		0
Stock Repurchased During Period, Value	(2,720)
Payment of Ordinary Dividends, Common Stock Class A	(10,671)	(10,822)
Payment of Ordinary Dividends, Common Stock Class B	(720)	(711)
Common Stock [Member]
Schedule Of Stockholders Equity [Line Items]
Common Stock, Value, Issued	548	548	548	548
Additional Paid-in Capital [Member]
Schedule Of Stockholders Equity [Line Items]
Additional paid-in capital	332,121	327,241	331,761	329,969
Stock Issued During Period, Value, Stock Options Exercised	(3,246)	(6,410)
Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation	32	64
Share-based Payment Arrangement, Noncash Expense	3,574	3,618
Retained Earnings [Member]
Schedule Of Stockholders Equity [Line Items]
Retained earnings	726,546	663,808	704,456	637,843
Net income		37,498
Payment of Ordinary Dividends, Common Stock Class A	(10,671)	(10,822)
Payment of Ordinary Dividends, Common Stock Class B	(720)	(711)
Treasury Stock [Member]
Schedule Of Stockholders Equity [Line Items]
Treasury Stock, Value	(109,146)	(43,779)	(107,216)	$ (46,332)
Stock Issued During Period, Value, Stock Options Exercised	(790)	(2,553)
Treasury Stock, Value, Acquired, Cost Method		0
Stock Repurchased During Period, Value	2,720
AOCI Attributable to Parent [Member]
Schedule Of Stockholders Equity [Line Items]
Accumulated other comprehensive loss	(69,668)	(71,283)	$ (66,477)
Other Comprehensive Income (Loss), Net of Tax	$ (3,191)	$ (29)

XML

Stock-Based Compensation - Stock Option Assumptions (Detail) - $ / shares	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Expected term (in years)	6 years 2 months 15 days	6 years 2 months 12 days
Expected volatility	30.71%	25.85%
Expected dividend yield	2.49%	2.63%
Risk-free interest rate	0.38%	1.64%
Options, Grants in Period, Weighted Average Exercise Price	$ 39.92	$ 54.05
Weighted-average fair value of options granted during the period	$ 8.65	$ 10.63

XML

Stock-Based Compensation Service-Based Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Service-Based Stock Options [Abstract]
Employee Service Share-based Compensation, Tax Benefit from Exercise of Stock Options	$ 93	$ 2,541
Fair value of options vested	$ 2,371	$ 2,537
Options Outstanding at July 31, 2020	1,273,382
Options, Grants in Period	303,052
Options, Grants in Period, Weighted Average Exercise Price	$ 39.92	$ 54.05
Options, Exercised in Period	(22,300)
Options, Exercises in Period, Weighted Average Exercise Price	$ 29.10
Options Forfeited in Period, Number of Shares	0
Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price	$ 0
Options Outstanding, Weighted Average Exercise Price	$ 37.84
Options, Outstanding, Intrinsic Value	$ 5,410
Options Outstanding, Weighted Average Remaining Contractual Term	7 years 2 months 12 days
Options Outstanding at October 31, 2020	1,554,134
Options Outstanding, Weighted Average Exercise Price	$ 38.37
Options Exercisable	1,004,641
Options Exercisable, Weighted Average Exercise Price	$ 34.88
Options Exercisable, Weighted Average Remaining Contractual Term	6 years 1 month 6 days
Options, Exercises in Period, Intrinsic Value	$ 373	$ 10,225
Options, Exercisable, Intrinsic Value	$ 5,410

XML

Stock-Based Compensation - Summary of Stock Option Activity under Company's Share-Based Compensation Plans (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Service Based Restricted Shares and Restricted Stock Units [Line Items]
Time-Based RSUs, Vested in Period, Fair Value	$ 5,844	$ 8,708
Performance Based Restricted Shares and Restricted Stock Units [Member] [Member]
Service Based Restricted Shares and Restricted Stock Units [Line Items]
Outstanding at July 31, 2020	126,060
Outstanding at July 31, 2020, Weighted Average Grant Date Fair Value	$ 50.61
Service-Based RSUs, Grants in Period	64,634
Service-Based RSUs, Grants in Period, Weighted Average Grant Date Fair Value	$ 60.73
Service-Based RSUs, Vested in Period	(71,413)
Service-Based RSUs, Vested in Period, Weighted Average Grant Date Fair Value	$ 33.12
Service-Based RSUs, Forfeited in Period	0
Service-Based RSUs, Forfeitures, Weighted Average Grant Date Fair Value	$ 0
Outstanding at October 31, 2020	119,281
Outstanding at October 31, 2020, Weighted Average Grant Date Fair Value	$ 61.05
Service Based Restricted Shares and Restricted Stock Units [Member]
Service Based Restricted Shares and Restricted Stock Units [Line Items]
Outstanding at July 31, 2020	154,960
Outstanding at July 31, 2020, Weighted Average Grant Date Fair Value	$ 47.39
Service-Based RSUs, Grants in Period	75,352
Service-Based RSUs, Grants in Period, Weighted Average Grant Date Fair Value	$ 39.92
Service-Based RSUs, Vested in Period	(63,339)
Service-Based RSUs, Vested in Period, Weighted Average Grant Date Fair Value	$ 44.85
Service-Based RSUs, Forfeited in Period	0
Service-Based RSUs, Forfeitures, Weighted Average Grant Date Fair Value	$ 0
Outstanding at October 31, 2020	166,973
Outstanding at October 31, 2020, Weighted Average Grant Date Fair Value	$ 44.98

XML

Stock Based Compensation - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from exercise of stock options	$ 160	$ 3,411
Stock-Based Compensation Expense
Share-based compensation expense	3,574	3,618
Share-based compensation expense, net of tax	3,300	3,089
Unrealized compensation cost related to share-based compensation, pre tax	$ 14,460
Weighted average period remaining	2 years 2 months 12 days
Stock Options, Additional Disclosures
Fair value of options vested	$ 2,371	2,537
Employee Service Share-based Compensation, Tax Benefit from Exercise of Stock Options	93	2,541
Service-Based RSUs, Additional Disclosures
Time-Based RSUs, Vested in Period, Fair Value	5,844	8,708
Options, Exercises in Period, Intrinsic Value	$ 373	$ 10,225
Service Based Restricted Shares and Restricted Stock Units [Member]
Service-Based RSUs, Additional Disclosures
Service-Based RSUs, Grants in Period, Weighted Average Grant Date Fair Value	$ 39.92

XML

Stock-Based Compensation Performance Based Restricted Shares and Restricted Stock Units (Details)	3 Months Ended
	Oct. 31, 2020 $ / shares shares
Service Based Restricted Shares and Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at July 31, 2020 | shares	154,960
Outstanding at July 31, 2020, Weighted Average Grant Date Fair Value | $ / shares	$ 47.39
Performance-Based RSUs, Grants in Period | shares	75,352
Performance-Based RSUs, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares	$ 39.92
Performance-Based RSUs, Vested in Period | shares	(63,339)
Performance-Based RSUs, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares	$ 44.85
Performance-Based RSUs, Forfeited in Period | shares	0
Performance-Based RSUs, Forfeitures, Weighted Average Grant Date Fair Value | $ / shares	$ 0
Outstanding at October 31, 2020 | shares	166,973
Outstanding at October 31, 2020, Weighted Average Grant Date Fair Value | $ / shares	$ 44.98
Performance Based Restricted Shares and Restricted Stock Units [Member] [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at July 31, 2020 | shares	126,060
Outstanding at July 31, 2020, Weighted Average Grant Date Fair Value | $ / shares	$ 50.61
Performance-Based RSUs, Grants in Period | shares	64,634
Performance-Based RSUs, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares	$ 60.73
Performance-Based RSUs, Vested in Period | shares	(71,413)
Performance-Based RSUs, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares	$ 33.12
Performance-Based RSUs, Forfeited in Period | shares	0
Performance-Based RSUs, Forfeitures, Weighted Average Grant Date Fair Value | $ / shares	$ 0
Outstanding at October 31, 2020 | shares	119,281
Outstanding at October 31, 2020, Weighted Average Grant Date Fair Value | $ / shares	$ 61.05

XML

Other Comprehensive Income Schedule of Accumulated Other Comprehensive Income (Loss), Net of Tax (Detail) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	$ (66,477)	$ (71,254)
Other comprehensive income before reclassification	(3,484)	362
Amounts reclassified from accumulated other comprehensive loss	(293)	391
Ending balance	(69,668)
Unrealized (loss) gain on cash flow hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(200)	707
Other comprehensive income before reclassification	701	136
Amounts reclassified from accumulated other comprehensive loss	(159)	286
Ending balance	660	557
Foreign currency translation adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(68,458)	(74,761)
Other comprehensive income before reclassification	(4,185)	226
Ending balance	(72,643)	(74,535)
Unamortized gain on post-retirement plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	2,181	2,800
Amounts reclassified from accumulated other comprehensive loss	(134)	105
Ending balance	$ 2,315	$ 2,695

XML

Other Comprehensive Income Schedule of Other Comprehensive Income, Tax (Detail) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Other Comprehensive Income (Loss), Tax [Abstract]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax	$ (48)	$ 35
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Plan Amendments, Tax Effect	240
Other Comprehensive Income Tax Other Adjustments	7	176
Other Comprehensive Income (Loss), Tax	$ 199	$ 211

XML

Segment Information - Schedule of Segment Reporting Information By Segment (Detail) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Segment Reporting Information [Line Items]
Net sales	$ 277,227	$ 286,947
Segment Profit	48,267	47,600
ID Solutions
Segment Reporting Information [Line Items]
Net sales	198,192	214,987
Segment Profit	40,279	42,443
Workplace Safety
Segment Reporting Information [Line Items]
Net sales	79,035	71,960
Segment Profit	7,988	5,157
Americas
Segment Reporting Information [Line Items]
Net sales	157,298	173,666
Americas | ID Solutions
Segment Reporting Information [Line Items]
Net sales	133,267	149,363
Americas | Workplace Safety
Segment Reporting Information [Line Items]
Net sales	24,031	24,303
Europe
Segment Reporting Information [Line Items]
Net sales	83,848	79,407
Europe | ID Solutions
Segment Reporting Information [Line Items]
Net sales	42,582	43,381
Europe | Workplace Safety
Segment Reporting Information [Line Items]
Net sales	41,266	36,026
Asia-Pacific
Segment Reporting Information [Line Items]
Net sales	36,081	33,874
Asia-Pacific | ID Solutions
Segment Reporting Information [Line Items]
Net sales	22,343	22,243
Asia-Pacific | Workplace Safety
Segment Reporting Information [Line Items]
Net sales	$ 13,738	$ 11,631

XML

Segment Information - Net Income Reconciliation (Detail) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Segment Reconciliation [Abstract]
Total profit from reportable segments	$ 48,267	$ 47,600
Unallocated amounts:
Administrative costs	(6,079)	(6,709)
Investment and other income	155	1,380
Interest expense	(106)	(701)
Income before income taxes and losses of unconsolidated affiliate	$ 42,237	$ 41,570

XML

Net Income per Common Share - Reconciliation of Numerator and Denominator of Basic and Diluted Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Earnings Per Share [Line Items]
Net income	$ 33,481	$ 37,498
Denominator for basic income per share for both Class A and Class B	52,021	53,143
Plus: Effect of dilutive equity awards	271	593
Denominator for diluted income per share for both Class A and Class B	52,292	53,736
Class A Nonvoting Common Stock
Earnings Per Share [Line Items]
Net income per share, basic	$ 0.64	$ 0.71
Net income per share, diluted	$ 0.64	$ 0.70
Class B Voting Common Stock
Earnings Per Share [Line Items]
Preferential dividends	$ (808)	$ (828)
Preferential dividends on dilutive stock options	(4)	(10)
Net income	$ 32,669	$ 36,660
Net income per share, basic	$ 0.63	$ 0.69
Net income per share, diluted	$ 0.62	$ 0.68

XML

Net Income per Common Share - Additional Informations (Detail) - shares	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Earnings Per Share [Abstract]
Common stock of Class A shares excluded from computations of diluted net income per share	740,745	323,719

XML

Fair Value Measurements - Financial Assets and Liabilities Accounted for at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Jul. 31, 2020
Fair Value, Inputs, Level 1 [Member] | Other Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading securities	$ 17,434	$ 18,606
Fair Value, Inputs, Level 2 [Member] | Prepaid expenses and other current assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign exchange contracts	1,017	594
Fair Value, Inputs, Level 2 [Member] | Other current liabilities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign exchange contracts	$ 449	$ 777

XML

Derivatives and Hedging Activities - Fair Values of Derivative Instruments in Consolidated Balance Sheets (Detail) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Jul. 31, 2020	Jul. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Accumulated other comprehensive loss	$ (69,668)		$ (66,477)	$ (71,254)
Foreign Currency Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net	(211)	$ 381
Prepaid expenses and other current assets [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives Assets	1,017		594
Other current liabilities [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives Liabilities	(449)		777
Unrealized (loss) gain on cash flow hedges
Derivative Instruments, Gain (Loss) [Line Items]
Net gain recognized in other comprehensive loss	697	$ 196
Unrealized (loss) gain on cash flow hedges | Designated as hedging instruments [Member] | Prepaid expenses and other current assets [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives Assets	1,017		588
Unrealized (loss) gain on cash flow hedges | Designated as hedging instruments [Member] | Other current liabilities [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives Liabilities	$ (434)		$ 761

XML

Derivatives and Hedging Activities - Additional Information (Detail) - USD ($)	3 Months Ended
	Oct. 31, 2020	Jul. 31, 2020	Oct. 31, 2019
Summary
Derivative maturity	18 months
Summary of Cash Flow Hedge Activity
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months	$ (523)	$ 385
Cash Flow Hedge Gain (Loss) Reclassified from OCI to Earnings	211,000		$ (381,000)
Prepaid expenses and other current assets [Member]
Derivatives, Fair Value [Line Items]
Derivatives Assets	1,017,000	594,000
Other current liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivatives Liabilities	(449,000)	777,000
Unrealized (loss) gain on cash flow hedges | Designated as hedging instruments [Member] | Prepaid expenses and other current assets [Member]
Derivatives, Fair Value [Line Items]
Derivatives Assets	1,017,000	588,000
Unrealized (loss) gain on cash flow hedges | Designated as hedging instruments [Member] | Other current liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivatives Liabilities	(434,000)	761,000
Unrealized (loss) gain on cash flow hedges | Not designated as hedging Instruments [Member | Prepaid expenses and other current assets [Member]
Derivatives, Fair Value [Line Items]
Derivatives Assets	0	6,000
Unrealized (loss) gain on cash flow hedges | Not designated as hedging Instruments [Member | Other current liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivatives Liabilities	$ (15,000)	$ 16,000

XML

Derivatives and Hedging Activities Notional Amount of Derivative Contracts (Details) - USD ($) $ in Thousands	Oct. 31, 2020	Jul. 31, 2020
Derivative [Line Items]
Derivative, Notional Amount	$ 22,489	$ 27,707
Designated as hedging instruments [Member]
Derivative [Line Items]
Derivative, Notional Amount	19,247	24,600
Not designated as hedging Instruments [Member
Derivative [Line Items]
Derivative, Notional Amount	$ 3,242	$ 3,107

XML

Income Taxes Effective Income Tax Rate (Details)	3 Months Ended
	Oct. 31, 2020 Rate	Oct. 31, 2019 Rate
Income Tax Disclosure [Abstract]
Effective Income Tax Rate Reconciliation, Percent	20.30%	9.80%

XML

Subsequent Events - Additional Information (Detail)	Nov. 17, 2020 $ / shares
Subsequent Event [Member]
Subsequent Event [Line Items]
Dividends Payable, Amount Per Share	$ 0.22